<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004931.pub2" GROUP_ID="ENDOC" ID="532400120522010940" MERGED_FROM="" MODIFIED="2008-11-10 11:23:19 +0100" MODIFIED_BY="Gudrun Paletta" REVIEW_NO="01" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2008-11-10 11:23:19 +0100" MODIFIED_BY="Gudrun Paletta">
<TITLE MODIFIED="2008-10-23 10:00:01 +0200" MODIFIED_BY="Gudrun Paletta">Intragastric balloon for obesity</TITLE>
<CONTACT MODIFIED="2008-11-10 11:23:19 +0100" MODIFIED_BY="Gudrun Paletta"><PERSON ID="18318" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Marcos</FIRST_NAME><MIDDLE_INITIALS>AP</MIDDLE_INITIALS><LAST_NAME>Fernandes</LAST_NAME><POSITION>Teacher</POSITION><EMAIL_1>iobesidade@uol.com.br</EMAIL_1><URL>www.iobesidade.com.br</URL><ADDRESS><DEPARTMENT>Department of Clinical Surgery</DEPARTMENT><ORGANISATION>University of  Medicine of Petropolis</ORGANISATION><ADDRESS_1>Rua Almirante Saldanha, 184</ADDRESS_1><ADDRESS_2>Cremerie</ADDRESS_2><CITY>Petrópolis</CITY><ZIP>25645-230</ZIP><REGION>Rio de Janeiro</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 24 2231 5530</PHONE_1><PHONE_2>+55 24 2245 0691</PHONE_2><FAX_1>+55 24 2231 5530</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2008-11-10 11:23:19 +0100" MODIFIED_BY="Gudrun Paletta"><PERSON ID="18318" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Marcos</FIRST_NAME><MIDDLE_INITIALS>AP</MIDDLE_INITIALS><LAST_NAME>Fernandes</LAST_NAME><POSITION>Teacher</POSITION><EMAIL_1>iobesidade@uol.com.br</EMAIL_1><URL>www.iobesidade.com.br</URL><ADDRESS><DEPARTMENT>Department of Clinical Surgery</DEPARTMENT><ORGANISATION>University of  Medicine of Petropolis</ORGANISATION><ADDRESS_1>Rua Almirante Saldanha, 184</ADDRESS_1><ADDRESS_2>Cremerie</ADDRESS_2><CITY>Petrópolis</CITY><ZIP>25645-230</ZIP><REGION>Rio de Janeiro</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 24 2231 5530</PHONE_1><PHONE_2>+55 24 2245 0691</PHONE_2><FAX_1>+55 24 2231 5530</FAX_1></ADDRESS></PERSON><PERSON ID="5183" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Álvaro</FIRST_NAME><MIDDLE_INITIALS>N</MIDDLE_INITIALS><LAST_NAME>Atallah</LAST_NAME><SUFFIX>MD, PhD.</SUFFIX><POSITION>Professor of Emergency Medicine and Evidence-Based Medicine, Director of Brazilian Cochrane Centre</POSITION><EMAIL_1>atallahmbe@uol.com.br</EMAIL_1><EMAIL_2>cochrane.dmed@epm.br</EMAIL_2><MOBILE_PHONE>+55 11 8173 0404</MOBILE_PHONE><ADDRESS><DEPARTMENT>Brazilian Cochrane Centre</DEPARTMENT><ORGANISATION>Universidade Federal de  São Paulo / Escola Paulista de Medicina</ORGANISATION><ADDRESS_1>Rua Pedro de Toledo 598 </ADDRESS_1><ADDRESS_2>Vila Clementino</ADDRESS_2><CITY>São Paulo</CITY><ZIP>CEP 04039-001</ZIP><REGION>SP</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 11 5575 2970</PHONE_1><PHONE_2>+55 11 5571 4721</PHONE_2><FAX_1>+55 11 5579 0469</FAX_1></ADDRESS></PERSON><PERSON ID="9639" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Bernardo </FIRST_NAME><LAST_NAME>Soares</LAST_NAME><POSITION>Honorary Fellow</POSITION><EMAIL_1>bgos@terra.com.br</EMAIL_1><ADDRESS><ORGANISATION>Brazilian Cochrane Centre</ORGANISATION><ADDRESS_1>Rua Pedro de Toledo 598</ADDRESS_1><ADDRESS_2>Vila Clementino</ADDRESS_2><CITY>São Paulo</CITY><ZIP>04039-001</ZIP><REGION>SP</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 11 5575 2970</PHONE_1><FAX_1>+55 11 5579 0469</FAX_1></ADDRESS></PERSON><PERSON ID="5179" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Humberto</FIRST_NAME><LAST_NAME>Saconato</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>hsaconato@uol.com.br</EMAIL_1><EMAIL_2>hsaconato@yahoo.com.br</EMAIL_2><ADDRESS><DEPARTMENT>Department of Medicine</DEPARTMENT><ORGANISATION>Federal University of Rio Grande do norte</ORGANISATION><ADDRESS_1>Alameda jauaperi 1083</ADDRESS_1><CITY>São Paulo</CITY><ZIP>04523-014</ZIP><REGION>Vila Clementino</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1> +55 11 6012-5472 </PHONE_1><PHONE_2>+55 11 5575-2970 </PHONE_2><FAX_1>+55 11 5575-2970 </FAX_1></ADDRESS></PERSON><PERSON ID="E7D5088482E26AA20078D4E6F34B8EC1" ROLE="AUTHOR"><PREFIX>Miss</PREFIX><FIRST_NAME>Sandra</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Guimarães</LAST_NAME><ADDRESS><ORGANISATION/><ADDRESS_1>Rua Almirante Saldanha, 184</ADDRESS_1><ADDRESS_2>Cremerie</ADDRESS_2><CITY>Petrópolis</CITY><ZIP>25645-230</ZIP><REGION>Rio de Janeiro</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 24 2231 5530</PHONE_1><PHONE_2>+55 24 2245 0691</PHONE_2><FAX_1>+55 24 22315530</FAX_1></ADDRESS></PERSON><PERSON ID="8641" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Delcio</FIRST_NAME><LAST_NAME>Matos</LAST_NAME><SUFFIX>MD, PhD.</SUFFIX><POSITION>Professor</POSITION><EMAIL_1>dmatos.dcir@epm.br</EMAIL_1><ADDRESS><DEPARTMENT>Brazilian Cochrane Centre</DEPARTMENT><ORGANISATION>FESP ? Escola Paulista de Medicina</ORGANISATION><ADDRESS_1>Rua Edison 278, Apto 61, Campo Belo </ADDRESS_1><CITY>São Paulo</CITY><ZIP>04618-031 </ZIP><REGION>São Paulo</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 011 50847551 </PHONE_1><FAX_1>+55 11 50847551</FAX_1></ADDRESS></PERSON><PERSON ID="E7D5071C82E26AA20078D4E64803C37A" ROLE="AUTHOR"><PREFIX>Miss</PREFIX><FIRST_NAME>Larissa</FIRST_NAME><MIDDLE_INITIALS>R</MIDDLE_INITIALS><LAST_NAME>Carneiro Monteiro</LAST_NAME><EMAIL_1>lartza@ibest.com.br</EMAIL_1><ADDRESS><ORGANISATION/><ADDRESS_1>Av. Visconde de Albuquerque 694 ap. 202</ADDRESS_1><ADDRESS_2>Leblon</ADDRESS_2><CITY>Rio de Janeiro</CITY><ZIP>22450-000</ZIP><REGION>Rio de Janeiro</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55212249 4774</PHONE_1><PHONE_2>+55212294 3034</PHONE_2><FAX_1>+5521 22494774</FAX_1></ADDRESS></PERSON><PERSON ID="9039" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Bernd</FIRST_NAME><LAST_NAME>Richter</LAST_NAME><POSITION>Coordinating Editor Metabolic and Endocrine Disorders Cochrane Review Group</POSITION><EMAIL_1>richterb@uni-duesseldorf.de</EMAIL_1><ADDRESS><DEPARTMENT>Department of General Practice</DEPARTMENT><ORGANISATION>Universitaetsklinikum Duesseldorf, Heinrich-Heine University</ORGANISATION><ADDRESS_1>PO Box 101007</ADDRESS_1><CITY>Duesseldorf</CITY><ZIP>40001</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 211 8118773</PHONE_1><FAX_1>+49 211 8118693</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-11-10 10:57:46 +0100" MODIFIED_BY="Gudrun Paletta">
<UP_TO_DATE>
<DATE DAY="31" MONTH="7" YEAR="2006"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="7" YEAR="2006"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="15" MONTH="11" YEAR="2009"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2004"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2007"/>
</DATES>
<WHATS_NEW>
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="3" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-10-23 09:59:41 +0200" MODIFIED_BY="Gudrun Paletta"/>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-11-10 11:20:14 +0100" MODIFIED_BY="Gudrun Paletta">
<SUMMARY MODIFIED="2008-11-10 11:19:53 +0100" MODIFIED_BY="Gudrun Paletta">
<TITLE MODIFIED="2008-10-23 10:00:15 +0200" MODIFIED_BY="Gudrun Paletta">Intragastric balloon for obesity</TITLE>
<SUMMARY_BODY MODIFIED="2008-11-10 11:19:53 +0100" MODIFIED_BY="Gudrun Paletta">
<P>With the failure of conventional treatments like diet therapy, increased physical activity and drug therapy in producing long lasting weight loss in people with obesity, other approaches like surgery are performed in specialised centres, an option to be considered for patients with morbid obesity who do not respond to clinical treatment. The silicon intragastric balloon (IGB) has been developed as a temporary aid to especially achieve weight loss in obese people with 40% or more their optimal weight, who have had unsatisfactory results in their treatment for obesity, despite of being cared for by a multidisciplinary team and in super obese patients who often have a high risk for surgery. The placement and removal of the IGB is an interventionist endoscopic procedure and the balloon is designed to float freely inside the stomach, its size might be changed during the placement. The IGB technique reduces the volume of the stomach and leads to a premature feeling of satiety<BR/>Nine randomised controlled trials involving 395 patients were evaluated. Six out of nine studies had a follow-up of less than one year, the longest study duration was 24 months. The overall quality of trials was variable, only a third of the analysed studies showed a low risk of bias. No information was available on quality of life, all-cause mortality and morbidity. Compared with conventional management, IGB did not show convincing evidence of a greater weight loss. The relative risks for minor complications, for example gastric ulcers and erosions were significantly raised.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Obesity is one of the major public health problems of modern society. Intragastric balloon (IGB) treatment for obesity has been developed as a temporary aid. Its primary objective is the treatment of obese people, who have had unsatisfactory results in their clinical treatment for obesity, despite of being cared for by a multidisciplinary team, and super obese patients with a higher surgical risk. However, the effects of different IGB procedures compared with conventional treatments and with each other are uncertain.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the effects of intragastric balloon in people with obesity.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>Studies were obtained from computerised searches of MEDLINE, EMBASE, LILACS, <I>The Cochrane Library</I> and other electronic databases. Furthermore, reference lists of relevant articles and hand searches of selected journals were performed. Experts in the field were contacted.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P> Randomised and quasi-randomised controlled trials fulfilling the inclusion criteria were used. Short term weight loss is common, so studies were included if they reported measurements after a minimum of four weeks follow-up. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Data were extracted by one reviewer and checked independently by two reviewers. Two reviewers independently assessed the quality of trials.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Nine randomised controlled trials involving 395 patients were included. Six out of nine studies had a follow-up of less than one year, the longest study duration was 24 months. Only a third of the analysed studies revealed a low risk of bias. No information was available on quality of life, all-cause mortality and morbidity. Compared with conventional management, IGB did not show convincing evidence of a greater weight loss. On the other hand, complications of intragastric balloon placement occurred, however few of a serious nature. The relative risks for minor complications like gastric ulcers and erosions were significantly raised.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P> Evidence from this review is limited for decision making, since there was large heterogeneity in IGB trials, regarding both methodological and clinical aspects. However, a co-adjuvant factor described by some authors in the loss and maintenance of weight has been the motivation and the encouragement to changing eating habits following a well-organized diet and a program of behavioural modification. The IGB alone and the technique of positioning appear to be safe. Despite the evidence for little additional benefit of the intragastric balloon in the loss of weight, its cost should be considered against a program of eating and behavioural modification.<BR/>
<U> </U> </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-10 11:20:14 +0100" MODIFIED_BY="Gudrun Paletta">
<BACKGROUND MODIFIED="2008-11-10 11:20:10 +0100" MODIFIED_BY="Gudrun Paletta">
<CONDITION MODIFIED="2008-11-10 11:19:58 +0100" MODIFIED_BY="Gudrun Paletta">
<P>Obesity is a universal disease with a progressive growing prevalence, which has reached epidemic alarming proportions, being one of the major public health problems of modern society (<LINK REF="REF-Adami-1995" TYPE="REFERENCE">Adami 1995</LINK>; <LINK REF="REF-Alvarez-1998" TYPE="REFERENCE">Alvarez 1998</LINK>). Treatment for patients with obesity should aim for the improvement and well-being besides the metabolic health of the individual, decreasing the risk for future diseases. Although most patients, frequently, look for cosmetic results as part of their expectations, this is not supposed to be the main outcome of such treatment. With the failure of the conventional treatments (diet therapy, increased physical activity, behaviour change and drug therapy) in producing permanent weight loss in patients with pathological obesity, other approaches have become more popular, for example bariatric surgery in specialised centres, an option to be considered for patients with morbid obesity who are resistant to clinical treatment (<LINK REF="REF-Buchwald-1984" TYPE="REFERENCE">Buchwald 1984</LINK>; <LINK REF="REF-Jung-2000" TYPE="REFERENCE">Jung 2000</LINK>). In the same way, the silicon intragastric balloon has been developed as a temporary aid. Its primary objective is the treatment of obese patients with 40% or more their optimal weight, who have had unsatisfactory results in their clinical treatment for obesity, despite of being treated by a multidisciplinary team and super obese patients with higher surgical risks (these patients weight loss may minimize anaesthetic, surgical and clinical risks).<BR/>The prevalence of morbid obesity in developed countries, such as the United Kingdom, is about 1.9% for women and 0.6% for men (<LINK REF="REF-Erens-1999" TYPE="REFERENCE">Erens 1999</LINK>) and approximately 2.9% among American adults (<LINK REF="REF-Alvarez-1998" TYPE="REFERENCE">Alvarez 1998</LINK>). It is estimated that the prevalence of obesity in the adult population in Brazil (the largest country of South America) reaches 15% to 20%, of which 3% to 5% show morbid obesity, corresponding to 5.9% of men and 13.3% of women (<LINK REF="REF-Monteiro-1998" TYPE="REFERENCE">Monteiro 1998</LINK>). It is known that the amount of people who are overweight equals the amount of malnourished people across the planet. Obesity is associated with several chronic diseases, such as diabetes mellitus, dyslipidaemia, heart and brain vascular diseases, coagulating alterations, degenerative diseases of the joints, oestrogen-dependent neoplasia, gallbladder neoplasia, hepatic steatosis (with or without cirrhosis) and sleep apnea. Obese and morbid obese patients (morbid obesity is also known as severe or grave obesity) show a higher risk of mortality (<LINK REF="REF-Agras-1993" TYPE="REFERENCE">Agras 1993</LINK>; <LINK REF="REF-Bray-1985" TYPE="REFERENCE">Bray 1985</LINK>; <LINK REF="REF-Seidell-1998" TYPE="REFERENCE">Seidell 1998</LINK>). In the long term, more than 95% of obese patients who are submitted to conventional treatments (diet therapy, increased physical activity, behaviour change and drug therapy) undergo the so called "rubber effect", which means that they cannot maintain the optimal weight and drop back to the previous weight; super and severe obese people almost always gain the lost weight back and sometimes put on some extra weight (<LINK REF="REF-Alvarez-1998" TYPE="REFERENCE">Alvarez 1998</LINK>; <LINK REF="REF-Manson-1995" TYPE="REFERENCE">Manson 1995</LINK>).<BR/>In 1991, the U.S. NIH (National Institute of Health) established a consensus of the implications of obesity on health, especially in relation to dyslipidaemia, diabetes mellitus, hypertension and some selected types of neoplasia, besides its economical and psychosocial problems. The NIH defined that an individual who has an BMI (body mass index) equal to or greater than 40 kg/m² would have an increase of weight equivalent to 100% or twice the optimal weight. Such individuals were defined as severe, grave or morbid obese and were characterised as having a higher risk of morbidity and mortality than a non-obese individual (<LINK REF="REF-Harvard-1991" TYPE="REFERENCE">Harvard 1991</LINK>).<BR/>According to the NIH, the candidates to the non-conventional treatment of the morbid obesity (as well as having an acceptable surgical risk) must have the following characteristics: BMI greater than 40 kg/m² or greater than 35 kg/m² in the presence of disease associated with obesity (co-morbidities such as type 2 diabetes, systemic hypertension, sleep apnea among others), in addition to previous inefficient clinical therapy, absence of endocrine abnormalities or endocrine diseases under clinical control, presence of complications of obesity that are solvable by weight loss, understanding of the inherent risks to a proposed procedure and possibility of postoperative follow-up (<LINK REF="REF-Deitel-1998" TYPE="REFERENCE">Deitel 1998</LINK>; <LINK REF="REF-Jung-2000" TYPE="REFERENCE">Jung 2000</LINK>).<BR/>The choice of treatment, however, must take into account the patient as a whole, and consider the benefit-risk ratio of surgical and non-surgical procedures. In clinical practice, the calculation of body mass index (BMI), also known as Quetelet index, obtained by the ratio of the patient's weight in kilograms and the squared patient's height in meters, is the most used quantitative measure for diagnosis of obesity (<LINK REF="REF-Deitel-1998" TYPE="REFERENCE">Deitel 1998</LINK>; <LINK REF="REF-Halpern-1999" TYPE="REFERENCE">Halpern 1999</LINK>; <LINK REF="REF-Seidell-1998" TYPE="REFERENCE">Seidell 1998</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2008-11-10 11:20:10 +0100" MODIFIED_BY="Gudrun Paletta">
<SUBSECTION>
<HEADING LEVEL="3">Surgical management options</HEADING>
<P>Surgical treatments have the primary intention of promoting the reduction of the patient's total volume of ingestion (with mechanical gastric restriction provoking a premature sensation of satiety) and promoting total or selective absorptive reduction of the content of food intake, or both (<LINK REF="REF-Deitel-1998" TYPE="REFERENCE">Deitel 1998</LINK>; <LINK REF="REF-Kusmak-1989" TYPE="REFERENCE">Kusmak 1989</LINK>).<BR/>A number of strategies have been developed: reduction of the gastric reservoir; increase in the time for gastric emptiness and reduction of the intestinal absorption area. Surgical treatment for morbid obesity are considered to be effective if there is an extra weight reduction of at least 50%, as well as the maintenance of such a weight loss (<LINK REF="REF-Deitel-1998" TYPE="REFERENCE">Deitel 1998</LINK>).<BR/>A New York doctor named Edward Mason, considered the precursor of modern surgery for obesity, introduced the technique of vertical banded gastroplasty, which predominated among specialists in the 1980s (<LINK REF="REF-Frandsen-1998" TYPE="REFERENCE">Frandsen 1998</LINK>). It is a vertical separation of the proximal stomach with a stapler forming a small chamber in the region of the cardia with a capacity of around 20 ml.<BR/>This surgery results, in the long term, in a weight loss of around 20% on average. However, patients with the habit of abundant candy intake have more disappointing results (<LINK REF="REF-Frandsen-1998" TYPE="REFERENCE">Frandsen 1998</LINK>; <LINK REF="REF-Mason-1998" TYPE="REFERENCE">Mason 1998</LINK>).<BR/>From the 1990s on, gastrojejunal derivation ("gastric bypass") added to the reduction in gastric capacity, with reduced relapse rates. The Capella Fobi technique (1991) uses such fundaments. It builds a small chamber with a "Silastic" ring that restricts this chamber exit which nevertheless flows into a gastrojejunal anastomosis, called "Roux-en-Y". This induces a functional restrictive factor which is an obstacle to the ingestion of food, especially sweets, by causing "dumping" like symptoms (<LINK REF="REF-Behrns-1993" TYPE="REFERENCE">Behrns 1993</LINK>; <LINK REF="REF-Capella-1991" TYPE="REFERENCE">Capella 1991</LINK>; <LINK REF="REF-Fobi-1998" TYPE="REFERENCE">Fobi 1998</LINK>). Its results show a long-term average weight reduction of 40%, associated with a decrease in morbidity. The relapse rates are less than 5%. The associated mortality is 1% (<LINK REF="REF-Behrns-1993" TYPE="REFERENCE">Behrns 1993</LINK>). An operation similar to Capella's technique, performed via a laparoscope, was introduced by Wittgrove and Clark in 1996 (<LINK REF="REF-Wittgrove-1996" TYPE="REFERENCE">Wittgrove 1996</LINK>).<BR/>More updated versions of malabsorptive operations have gained growing acceptance from the specialists, mainly in North America. These procedures reduce the stomach (subtotal gastrectomies) in association with intestine derivations, thereby lowering absorption to a less radical level compared to the jejunoileal "bypass". The Scorpinaro technique and the "duodenal switch", using those principles result in permanent weight losses around 40%. They have the advantage of allowing more abundant meals, similar to those gastrectomised patients are able to consume. Malnutrition rate are reported in the range of 3% to 5% of patients and there are some uncomfortable digestive disturbances (diarrhoea, meteorism) in a significant number of operated patients (<LINK REF="REF-Boman-1998" TYPE="REFERENCE">Boman 1998</LINK>; <LINK REF="REF-Jung-2000" TYPE="REFERENCE">Jung 2000</LINK>; <LINK REF="REF-Marceau-1988" TYPE="REFERENCE">Marceau 1988</LINK>; <LINK REF="REF-Scopinaro-1979" TYPE="REFERENCE">Scopinaro 1979</LINK>; <LINK REF="REF-Scopinaro-1998" TYPE="REFERENCE">Scopinaro 1998</LINK>).<BR/>The gastric band technique was first used by Forsell in 1985. Kuzmak, in 1986, performed this by using open surgery and a non-adjustable gastric band. Since 1995, the adjustable gastric band and the laparoscopic access have brought advantages to the technique. The gastric band technique consists of applying silicon proteases to the proximal stomach through laparoscopy, so that it "crushes" the passage and creates a small chamber together with the cardia, with a narrow exit orifice just like in Mason's operation (<LINK REF="REF-Mason-1967" TYPE="REFERENCE">Mason 1967</LINK>; <LINK REF="REF-Mason-1982" TYPE="REFERENCE">Mason 1982</LINK>). However, in this technique the exit orifice is adjustable through the puncturing of the inflatable proteases. This operation reduces hospital stay to one day and allows the patient to return to work in up to seven days (<LINK REF="REF-Ashy-1998" TYPE="REFERENCE">Ashy 1998</LINK>; <LINK REF="REF-Belachew-1993" TYPE="REFERENCE">Belachew 1993</LINK>; <LINK REF="REF-Belachew-1998" TYPE="REFERENCE">Belachew 1998</LINK>).<BR/>Presently, the adjustable gastric band technique is widely used all over Europe, Australia, Mexico, Brazil and in some American Centres. The adjustment is made without the necessity of surgery, through the addition or removal of a saline solution by means of puncturing the subcutaneous port. As it is a restrictive procedure, the gastric bandage avoids the problems associated with the malabsorptive techniques such as anaemia, dumping and vitamin and mineral deficiencies which are associated with reduced absorption. Complications related to the gastric band include those associated with the surgical procedure like splenic or oesophageal injuries, infection of the surgical scar, sliding of the band, and also complications which might occur later on, such as infection of the port, leak and emptiness of the band, intrusion (migration of the band into the interior of the stomach), persistent hyperemesis, failure in losing weight and acid reflux (<LINK REF="REF-Belachew-1998" TYPE="REFERENCE">Belachew 1998</LINK>; <LINK REF="REF-Terra-1997" TYPE="REFERENCE">Terra 1997</LINK>). Despite being considered as the most physiological procedure in the surgical treatment of morbid obesity, with low surgical and postoperative mortality as well as pre- and postoperative complications and good reductions of excess weight, there are some questions regarding its validity and its surgical effects are yet uncertain (<LINK REF="REF-Garrido-1998" TYPE="REFERENCE">Garrido 1998</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intragastric balloon (IGB)</HEADING>
<P>The intragastric balloon technique allows the reduction of the gastric reservoir capacity causing a premature sensation of satiety, making it easier for patients to consume small amounts of food. A low calorie diet including physical activity is recommended for people with obesity. The concept of metabolic health improvement of the patient is based on the idea that the weight loss of such a patient is just the initial phase of the treatment, with the maintenance of such weight loss being the main objective of therapy (<LINK REF="REF-Halpern-1999" TYPE="REFERENCE">Halpern 1999</LINK>).<BR/>Little weight loss may be followed by significant health improvements. Weight losses of around 5% to 10% may improve blood pressure, lipoproteins features, the number of apnea and hypopnoea events during sleep, diabetes mellitus and consequently the patients' preoperative conditions (<LINK REF="REF-Jung-1997" TYPE="REFERENCE">Jung 1997</LINK>; <LINK REF="REF-Young-1996" TYPE="REFERENCE">Young 1996</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Adverse effects of the intervention</HEADING>
<P>The technique has absolute contra-indications such as voluminous hiatus hernia, abnormalities of the pharynx and oesophagus, oesophagus varicose veins, use of anti-inflammatory or anti-coagulant drugs, pregnancy and psychiatric disorders. Relative contra-indications are oesophagitis, ulceration and acute lesions of the gastric mucous membrane. The complications of the IGB are related to the endoscopic method itself, to sedation and perforation, to its prolonged contact with the mucous membrane and its migration, which may result in oesophageal or intestinal obstruction (<LINK REF="REF-Mathus-1997" TYPE="REFERENCE">Mathus 1997</LINK>).<BR/>The patients must be clinically supervised during the IGB placement and must be informed about possible symptoms of oesophagus injury and vomiting due to possible IGB slippage and the consequent necessity of early endoscopic removal. Since the IGB works as an artificial bezoar, the patients usually show a maximal reduction in ingestion around the fourth week returning to normal after 12 weeks.</P>
</SUBSECTION>
</INTERVENTION>
<THEORY MODIFIED="2008-11-10 11:01:12 +0100" MODIFIED_BY="Gudrun Paletta">
<P>The concept of the intragastric balloon was developed through the observation of weight loss effects naturally caused by a bezoar (formation of great amounts of food balls impeding the gastric emptying). The intragastric balloon was developed by imitating the positive aspects of weight loss caused by a bezoar (<LINK REF="REF-Nieben-1982" TYPE="REFERENCE">Nieben 1982</LINK>).<BR/>The IGB was designed to be placed and closed, in the stomach by endoscopy (<LINK REF="REF-Sallet-2001" TYPE="REFERENCE">Sallet 2001</LINK>) being later on supplemented by the injection of physiological solution, acting as an artificial bezoar. It was thus designed to fluctuate freely inside the stomach allowing a volumetric adjustment during its placement (<LINK REF="STD-Gau-1989b" TYPE="STUDY">Gau 1989b</LINK>; <LINK REF="REF-Mathus-1997" TYPE="REFERENCE">Mathus 1997</LINK>; <LINK REF="STD-Scheiderman-1988b" TYPE="STUDY">Scheiderman 1988b</LINK>).<BR/>The placement and removal of the IGB is an interventionist endoscopic procedure (<LINK REF="REF-Zuccaro-2002" TYPE="REFERENCE">Zuccaro 2002</LINK>). It must also be taken into account that morbid obese patients have important clinical co-morbidities such as hypertension and coronary heart disease, which, associated with the pathophysiological alterations, place the patients in a high-risk group for hypoxaemia and arrhythmia during the endoscopic operation.<BR/>Among the safety regulations for endoscopic manoeuvres in morbid obese patients, it is suggested to use adequate beds to hold up the weight and the patient's size, as well as oxygen and resuscitation facilities. The patient must be sedated with individualised and adequate doses of benzodiazepines. The examination must be performed with capillary oximetry for cardiac and oxygen saturation monitoring. The patient must be clinically observed for a longer period of time. The accumulation of benzodiazepines in the fat compartment may lead to a more prolonged sedation after the procedure (<LINK REF="REF-Zuccaro-2002" TYPE="REFERENCE">Zuccaro 2002</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2008-10-23 10:59:32 +0200" MODIFIED_BY="Gudrun Paletta">
<P>The aim of using the IGB is to treat obese patients with 40% or more their optimal weight (defined by the Metropolitan Life Insurance (1983) weight and frame tables) who showed unsatisfactory results following clinical treatment for their condition, even after being cared for by a multidisciplinary team, and super obese people who have higher anaesthetic, clinical and surgical risks (<LINK REF="REF-Sallet-2001" TYPE="REFERENCE">Sallet 2001</LINK>).<BR/>Patients who undergo insertion of an IGB may consume a normal diet, especially liquids and programmed diets. The balloon has been designed to have its volume adjusted inside the stomach, thus allowing an optimisation of the weight loss.</P>
<P>Two systematic reviews of surgical interventions were published (<LINK REF="REF-Colquitt-2003" TYPE="REFERENCE">Colquitt 2003</LINK>; <LINK REF="REF-CRD-1997" TYPE="REFERENCE">CRD 1997</LINK>), but these reviews did not include IGB techniques. Therefore, a systematic review on IGB as a temporary aid in the treatment of patients with morbid obesity appears to be useful.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P>To assess the effects of intragastric balloon in people with obesity.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-10 11:20:14 +0100" MODIFIED_BY="Gudrun Paletta">
<SELECTION_CRITERIA MODIFIED="2008-11-10 11:20:14 +0100" MODIFIED_BY="Gudrun Paletta">
<CRIT_STUDIES>
<P>Randomised and quasi-randomised controlled trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Patients with overweight (body mass index (BMI) 25-29.9 kg/m²), obesity level I (BMI 30-34.9 kg/m²), obesity level II (BMI 35-39.9 kg/m²), obesity level III (BMI greater than 40 kg/m²) and super obese patients (BMI greater than 50 kg/m²). </P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Studies were included if they reported measurements after a minimum of four weeks follow-up. <BR/>
</P>
<UL>
<LI>intragastric balloon (IGB) compared to conventional treatments (diet therapy, physical activity, behaviour therapy, drug therapy);</LI>
<LI>IGB compared to no treatment;</LI>
<LI>IGB compared to intragastric balloon and diet therapy;</LI>
<LI>IGB and diet therapy compared to diet therapy only. </LI>
</UL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-11-10 11:20:14 +0100" MODIFIED_BY="Gudrun Paletta">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-11-10 11:20:14 +0100" MODIFIED_BY="Gudrun Paletta">
<UL>
<LI>weight loss;</LI>
<LI>other anthropometrical measures (e.g. body mass index, skinfold thickness, fat free mass, waist size);</LI>
<LI>adverse effects (for example technical failure in the procedure and eventual intragastric balloon defects).</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-10-23 11:01:28 +0200" MODIFIED_BY="Gudrun Paletta">
<UL>
<LI>quality of life, ideally measured with a validated instrument;</LI>
<LI>mortality (all-cause, postoperative);</LI>
<LI>revision rates (reversal with the early removal of the intragastric balloon);</LI>
<LI>major complications: migration, which may result in oesophageal or gastrointestinal obstruction;</LI>
<LI>minor complications: erosion or ulceration, or both, by permanent contact with the gastric mucous membrane;</LI>
<LI>obesity related co-morbidity (for example diabetes, hypertension);</LI>
<LI>costs.</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="5">Covariates, effect modifiers and confounders</HEADING>
<UL>
<LI>experience of the nutrition clinic staff and the motivation of the patients to change their eating habits and behavior in order to lose weight;</LI>
<LI>the utilization of two different kinds of balloons (Garren-Edwards of cylindrical format with sharp corners, primary system of valve and restricted volume; and the most recent BioEnterics Intragastric Balloon of oval format, soft surface without sharp corners, made of polyurethane and valve);</LI>
<LI>different volumes used for insufflation of the balloons;</LI>
<LI>use of the H<SUB>2</SUB> receptor blockers during the intervention.</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-11-10 11:03:09 +0100" MODIFIED_BY="Gudrun Paletta">
<ELECTRONIC_SEARCHES MODIFIED="2008-11-10 11:02:55 +0100" MODIFIED_BY="Gudrun Paletta">
<P>We used the following sources for the identification of trials:<BR/>
</P>
<UL>
<LI>
<I>The Cochrane Library</I> (Issue 3, 2005);</LI>
<LI>MEDLINE (until July 2006);</LI>
<LI>EMBASE (until July 2006);</LI>
<LI>LILACS (until July 2006).</LI>
</UL>
<P>
<BR/>We also searched databases of ongoing trials:<BR/>
</P>
<UL>
<LI>National Research Register Issue 3, 2005;</LI>
<LI>Early Warning System;</LI>
<LI>Current Controlled Trials;</LI>
<LI>MRC trials database.</LI>
</UL>
<P>
<BR/>The described search strategy (see for a detailed search strategy under <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>) was used for MEDLINE. For use with EMBASE and <I>The Cochrane Library </I>this strategy was slightly adapted.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2008-11-10 11:03:09 +0100" MODIFIED_BY="Gudrun Paletta">
<P>The following journals were hand searched for articles and conferences proceedings:<BR/>
</P>
<UL>
<LI>International Journal of Obesity (1997 to July 2006);</LI>
<LI>ABESO - (Brazilian Journal Association for Obesity Studies) (1986 to July 2006).</LI>
</UL>
<P>
<BR/>Congress annals for the national and international societies:<BR/>
</P>
<UL>
<LI>SBCB (Brazilian Society for Bariatric Surgery);</LI>
<LI>IFSO (International Federation for the Surgery of Obesity).</LI>
</UL>
<P>
<BR/>Authors of included studies and relevant experts were contacted when possible in order to obtain additional references, missing data, unpublished trials and any ongoing trials.</P>
<P>The scientific departments of the intragastric balloon manufacturers were also contacted:<BR/>
</P>
<UL>
<LI>Hélioscopie - France (www.helioscopie.fr);</LI>
<LI>BioEnterics Corporation / INAMED Development Company - USA (www.inamed.com).</LI>
</UL>
<P>
<BR/>We tried to identify additional studies by searching the reference lists of included trials and (systematic) reviews, meta-analyses and health technology assessment reports identified.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-11-10 11:07:19 +0100" MODIFIED_BY="Gudrun Paletta">
<STUDY_SELECTION MODIFIED="2008-10-23 11:03:21 +0200" MODIFIED_BY="Gudrun Paletta">
<P>The main reviewer (MF) inspected the titles, abstracts and keywords of every retrieved record, and part of these were re-inspected by the co-reviewers (ANA, BGOS, HS). Full articles were retrieved for further assessment if the information given suggested that the study fulfilled the inclusion criteria. If there was any doubt, the authors were contacted, and the articles were added to the "awaiting assessment" section. In case doubts persisted or if there was no clarification given by the authors, the review group editorial base would have been consulted. Interrater agreement for trial selection was measured using the kappa statistic (<LINK REF="REF-Cohen-1960" TYPE="REFERENCE">Cohen 1960</LINK>).</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2008-11-10 11:06:16 +0100" MODIFIED_BY="Gudrun Paletta">
<P>Data extraction was made independently by three reviewers (MF, LCM, SMG) using a data extraction form, which included the following information:<BR/>
</P>
<UL>
<LI>general information: published or unpublished, title, authors, reference or source, country, language for publication, year of publication, duplicated publication, sponsoring;</LI>
<LI>trial characteristics: methods, including randomisation (and method), allocation concealment (and method), blinding (patients, outcome assessors) and intention-to-treat analysis;</LI>
<LI>patients: sampling (random or consecutive), exclusion criteria, total number and number in comparison groups, sex, age, BMI, weight, similarity of groups at base line (including any co-morbidity), withdrawals and losses to follow-up (reasons or description), subgroups;</LI>
<LI>intervention(s): all available details, including surgical method, period of treatment and others;</LI>
<LI>outcomes: above specified outcomes, any other assessed outcomes, other events, length of follow-up, quality of outcomes reporting;</LI>
<LI>results: published data as well as intention-to-treat analysis for dichotomous variables.</LI>
</UL>
<P>
<BR/>Differences in data extraction were resolved by consensus among reviewers (MF, ANA, BGOS, HS) referring back to the original article.</P>
<SUBSECTION>
<HEADING LEVEL="4">Dealing with duplicate publications</HEADING>
<P>Where trials were reported in more than one publication, data were extracted from the most recent article, referring to other articles for methodological details, baseline characteristics or further outcomes.</P>
</SUBSECTION>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2008-10-23 11:03:37 +0200" MODIFIED_BY="Gudrun Paletta">
<P>The methodological quality of the trials included in this review was assessed using the criteria described in the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2005" TYPE="REFERENCE">Higgins 2005</LINK>), which are especially based on the evidence of a strong relationship between the potential for bias in the results and the concealment of allocation (<LINK REF="REF-Chalmers-1983" TYPE="REFERENCE">Chalmers 1983</LINK>; <LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>; <LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>).</P>
<P>The categories are defined below:<BR/>
</P>
<UL>
<LI>A - low risk of bias (adequate allocation concealment);</LI>
<LI>B - moderate risk of bias (some doubts about allocation concealment);</LI>
<LI>C - high risk of bias (inadequate allocation concealment).</LI>
</UL>
<P>For the purpose of the analyses in this review, trials were included if they had met the Cochrane criteria A or B.</P>
<P>The quality of each trial was based on the criteria of quality specified by (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>), which measures a wider range of factors that impact on the quality of the trial.<BR/>In particular the following factors were studied:<BR/>
</P>
<UL>
<LI>minimisation of selection bias: a) was the randomisation procedure adequate? b) was the allocation concealment adequate?</LI>
<LI>minimisation of attrition bias: a) were withdrawals and dropouts completely described? b) was analysis by intention-to-treat?</LI>
<LI>minimisation of detection bias: a) were outcome assessors blind to the intervention?</LI>
</UL>
<P>
<BR/>This classification was used as the basis of a sensitivity analysis. Additionally, we explored the influence of individual quality criteria in a sensitivity analyses.</P>
<P>Each trial was assessed independently by two reviewers (MF, HS). Interrater agreement was calculated using the kappa statistic (<LINK REF="REF-Cohen-1960" TYPE="REFERENCE">Cohen 1960</LINK>). In cases of disagreement, the rest of the group was consulted and a judgement made based on consensus.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2008-11-10 11:04:43 +0100" MODIFIED_BY="Gudrun Paletta">
<P>Dichotomous data were expressed as relative risks and their respective 95% confidence intervals (CI). Continuous data were expressed as weighted mean differences.</P>
</EFFECT_MEASURES>
<HETEROGENEITY_ASSESSMENT MODIFIED="2008-11-10 11:05:07 +0100" MODIFIED_BY="Gudrun Paletta">
<P>Statistical heterogeneity was also assessed by means of I squared (I²), ranging from 0% to 100% including its 95% confidence interval (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>). I squared (I²) demonstrates the percentage of total variation across studies due to heterogeneity and was used to judge the consistency of evidence and it was assumed to be substantial in case I² was greater than 50%.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2008-11-10 11:05:30 +0100" MODIFIED_BY="Gudrun Paletta">
<P>The funnel plot was planned to assess but not done due to the low number of included studies.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2008-11-10 11:05:26 +0100" MODIFIED_BY="Gudrun Paletta">
<P>Data were included in a meta-analysis if they were appropriately reported with number of events or means and standard deviations or errors as well as total number of patients in each group. Overall results were calculated based on the random effects model due to the expected methodological and clinical heterogeneity. Possible sources of heterogeneity were planned to be assessed by sensitivity and subgroup analyses as described below.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2008-10-23 11:04:48 +0200" MODIFIED_BY="Gudrun Paletta">
<P>The reviewers aimed to perform subgroup analyses in order to explore effect size differences according to the following characteristics:<BR/>
</P>
<UL>
<LI>overweight patients (BMI 25-29.9 kg/m²) versus obesity level I (BMI 30-34.9 kg/m²) versus obesity level II (BMI 35-39.9 kg/m²) versus obesity level III (BMI more than 40 kg/m²) versus super obese patients (BMI greater than 50 kg/m²);</LI>
<LI>age;</LI>
<LI>sex;</LI>
<LI>length of follow-up: depending on data.</LI>
</UL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2008-10-23 11:05:07 +0200" MODIFIED_BY="Gudrun Paletta">
<P>The authors planned to perform sensitivity analyses in order to explore the influence of the following factors on effect size:<BR/>
</P>
<UL>
<LI>repeating the analysis excluding unpublished studies (if there were any);</LI>
<LI>repeating the analysis taking account of study quality, as specified above;</LI>
<LI>repeating the analysis excluding any very long or large studies to establish how much they dominate the results;</LI>
<LI>repeating the analysis excluding studies using the following filters: diagnostic criteria, language of publication, source of funding (industry versus other), country.</LI>
</UL>
<P>
<BR/>The robustness of the results was also planned be tested by repeating the analysis using different measures of effects size (risk difference, odds ratio etc.) and different statistical models (fixed and random effects models).</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-11-10 11:17:06 +0100" MODIFIED_BY="Gudrun Paletta">
<STUDY_DESCRIPTION MODIFIED="2008-11-10 11:10:32 +0100" MODIFIED_BY="Gudrun Paletta">
<SEARCH_RESULTS MODIFIED="2008-11-10 11:08:38 +0100" MODIFIED_BY="Gudrun Paletta">
<P>Two-hundred and twenty articles were obtained in the search, of which 131 were excluded and 89 were evaluated in more detail. From these, 73 studies were excluded and nine trials included which were reported in 16 publications.</P>
<SUBSECTION>
<HEADING LEVEL="4">Interrater agreement</HEADING>
<P>Initial disagreements were resolved through discussion in all cases.</P>
</SUBSECTION>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2008-11-10 11:10:32 +0100" MODIFIED_BY="Gudrun Paletta">
<P>Nine studies in 16 publications met the inclusion criteria.</P>
<SUBSECTION>
<HEADING LEVEL="4">Study design</HEADING>
<P>The nine included studies were randomised and controlled clinical trials. The duration of the included trials were of three months in one study (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>), four months in one study (<LINK REF="STD-Rigaud-1994" TYPE="STUDY">Rigaud 1994</LINK>), six months in three studies (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>; <LINK REF="STD-Meshkinpour-1988" TYPE="STUDY">Meshkinpour 1988</LINK>; <LINK REF="STD-Ramhamdany-1989" TYPE="STUDY">Ramhamdany 1989</LINK>), nine months in one study (<LINK REF="STD-Mathus_x002d_Vliegen-1990" TYPE="STUDY">Mathus-Vliegen 1990</LINK>), 12 months in one study (<LINK REF="STD-Hogan-1989" TYPE="STUDY">Hogan 1989</LINK>), 15 months in one study (<LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>) and 24 months in one study (<LINK REF="STD-Mathus_x002d_Vliegen-2005" TYPE="STUDY">Mathus-Vliegen 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>A total of 395 patients were included in the nine trials. The individual studies size ranged from 20 (<LINK REF="STD-Rigaud-1994" TYPE="STUDY">Rigaud 1994</LINK>) to 90 (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>) patients. Most of the patients in the studies were female and aged between 14 and 64 years. Two studies described only the average age (<LINK REF="STD-Hogan-1989" TYPE="STUDY">Hogan 1989</LINK>; <LINK REF="STD-Rigaud-1994" TYPE="STUDY">Rigaud 1994</LINK>) and one trial does not report the age of the patients (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>). Where reported, median or mean preoperative weight of the study sample or subgroup ranged from 71.4 kg to 191.2 kg; four studies mentioned the average initial weight (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>; <LINK REF="STD-Hogan-1989" TYPE="STUDY">Hogan 1989</LINK>; <LINK REF="STD-Ramhamdany-1989" TYPE="STUDY">Ramhamdany 1989</LINK>; <LINK REF="STD-Rigaud-1994" TYPE="STUDY">Rigaud 1994</LINK>) one study described only the percentage above the ideal weight (<LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>) and one study did not mention the initial weight (<LINK REF="STD-Meshkinpour-1988" TYPE="STUDY">Meshkinpour 1988</LINK>) and BMI ranged between 29.7 kg/m² and 68 kg/m² ; four studies described the mean BMI (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>; <LINK REF="STD-Hogan-1989" TYPE="STUDY">Hogan 1989</LINK>; <LINK REF="STD-Ramhamdany-1989" TYPE="STUDY">Ramhamdany 1989</LINK>; <LINK REF="STD-Rigaud-1994" TYPE="STUDY">Rigaud 1994</LINK>); and one study described the percentage of BMI (<LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>).<BR/>The authors did not specify the prevalence of co-morbidities. Some studies described the calories ingested before the start of the treatment with the intragastric balloon (IGB) as a base for calculation of the suggested diet (<LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>; <LINK REF="STD-Rigaud-1994" TYPE="STUDY">Rigaud 1994</LINK>). Furthermore, authors did not describe the dissimilarities between the groups. Most of the authors did not compare the groups according to age, distribution of sex, weight or frequency of co-morbidities, such as hypertension, dyslipidaemia and diabetes mellitus.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>The included studies compared the following interventions:<BR/>
</P>
<UL>
<LI>intragastric balloon versus diet (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>; <LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>; <LINK REF="STD-Hogan-1989" TYPE="STUDY">Hogan 1989</LINK>; <LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>);</LI>
<LI>intragastric balloon versus no treatment (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>);</LI>
<LI>intragastric balloon versus intragastric balloon and diet (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>);</LI>
<LI>intragastric balloon and diet versus diet only (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-1990" TYPE="STUDY">Mathus-Vliegen 1990</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-2005" TYPE="STUDY">Mathus-Vliegen 2005</LINK>; <LINK REF="STD-Meshkinpour-1988" TYPE="STUDY">Meshkinpour 1988</LINK>; <LINK REF="STD-Ramhamdany-1989" TYPE="STUDY">Ramhamdany 1989</LINK>; <LINK REF="STD-Rigaud-1994" TYPE="STUDY">Rigaud 1994</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcome measures</HEADING>
<P>Several different measures of weight change were reported by the studies, including mean or median weight at follow-up: weight loss, percent ideal body weight, percent of initial weight, percent excess weight loss and proportion of "successes". Many of the studies did not report measures of variability such as confidence intervals or standard deviations.<BR/>Co-morbidities were reported in two studies (<LINK REF="STD-Mathus_x002d_Vliegen-2005" TYPE="STUDY">Mathus-Vliegen 2005</LINK>; <LINK REF="STD-Rigaud-1994" TYPE="STUDY">Rigaud 1994</LINK>); quality of life was not reported and there were no data mortality.<BR/>Costs were reported in one study (<LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>), the balloon and introducer costs were approximately 313 EURO (U.S. $ 400) and the endoscopic charges for insertion and removal of each balloon were 940 EURO to 1254 EURO (U.S. $ 1200 to U.S. $ 1600 ). Furthermore, this study demonstrated an additional 470 EURO (U.S. $ 600) for each kilogram of weight lost with the balloon.<BR/>Adverse events and additional procedures, or both, were reported by most studies.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2008-11-10 11:08:54 +0100" MODIFIED_BY="Gudrun Paletta">
<P>Seventy-three studies were excluded after examining the entire text. The studies were excluded for more than one reason, the commonest being the absence of one or more groups of comparison, or the absence of method of randomised allocation.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-11-10 11:12:34 +0100" MODIFIED_BY="Gudrun Paletta">
<P>For details of risk of bias see <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<P>Three randomised controlled trials were classified as having a moderate risk of bias, with one or more of the quality criteria only partly met (<LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-1990" TYPE="STUDY">Mathus-Vliegen 1990</LINK>; <LINK REF="STD-Meshkinpour-1988" TYPE="STUDY">Meshkinpour 1988</LINK>). One trial was classified as having a high risk of bias, with one or more of the criteria not met (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>). The remaining five trials were classified as having a low risk of bias (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>; <LINK REF="STD-Hogan-1989" TYPE="STUDY">Hogan 1989</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-2005" TYPE="STUDY">Mathus-Vliegen 2005</LINK>; <LINK REF="STD-Ramhamdany-1989" TYPE="STUDY">Ramhamdany 1989</LINK>; <LINK REF="STD-Rigaud-1994" TYPE="STUDY">Rigaud 1994</LINK>).<BR/>
</P>
<ALLOCATION MODIFIED="2008-11-10 11:11:55 +0100" MODIFIED_BY="Gudrun Paletta">
<P>All nine studies described randomisation procedures, but in two studies the methods of randomisation were not stated (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>; <LINK REF="STD-Meshkinpour-1988" TYPE="STUDY">Meshkinpour 1988</LINK>) and in two studies the methods of randomisation were not appropriate (<LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-1990" TYPE="STUDY">Mathus-Vliegen 1990</LINK>). Concealment of allocation was adequate in five studies (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>; <LINK REF="STD-Hogan-1989" TYPE="STUDY">Hogan 1989</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-2005" TYPE="STUDY">Mathus-Vliegen 2005</LINK>; <LINK REF="STD-Ramhamdany-1989" TYPE="STUDY">Ramhamdany 1989</LINK>; <LINK REF="STD-Rigaud-1994" TYPE="STUDY">Rigaud 1994</LINK>), with the remaining studies not reporting any concealment approach.</P>
</ALLOCATION>
<BLINDING MODIFIED="2008-11-10 11:12:17 +0100" MODIFIED_BY="Gudrun Paletta">
<P>Outcome assessors were reported to be blinded to the intervention in eight studies (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>; <LINK REF="STD-Hogan-1989" TYPE="STUDY">Hogan 1989</LINK>; <LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-1990" TYPE="STUDY">Mathus-Vliegen 1990</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-2005" TYPE="STUDY">Mathus-Vliegen 2005</LINK>; <LINK REF="STD-Meshkinpour-1988" TYPE="STUDY">Meshkinpour 1988</LINK>; <LINK REF="STD-Ramhamdany-1989" TYPE="STUDY">Ramhamdany 1989</LINK>; <LINK REF="STD-Rigaud-1994" TYPE="STUDY">Rigaud 1994</LINK>). In one study the outcome assessors were not blinded (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2008-11-10 11:12:07 +0100" MODIFIED_BY="Gudrun Paletta">
<P>Withdrawals and dropouts were described in all nine randomised controlled trials. However, only <LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK> did not carry out intention-to-treat analysis.</P>
</EXCLUSIONS>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-11-10 11:17:06 +0100" MODIFIED_BY="Gudrun Paletta">
<P>For details see <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> to <LINK REF="APP-11" TYPE="APPENDIX">Appendix 11</LINK>.</P>
<P>The results are presented separately for each comparison (intragastric balloon versus diet, intragastric balloon versus no treatment, intragastric balloon versus intragastric balloon plus diet, intragastric balloon plus diet versus diet only). Some studies reported outcomes of secondary interest to the present review. Complications were subdivided into major complications (migration of the balloon, intestinal obstruction, wounds by Mallory-Weiss syndrome and oesophageal laceration) and minor complications (gastric ulcers, gastric erosions, abdominal pain and vomiting).</P>
<SUBSECTION>
<HEADING LEVEL="3">Intragastric balloon versus diet (Benjamin 1988; Geliebter 1990; Hogan 1989; Lindor 1987)</HEADING>
<P>Benjamin compared the Garren-Edwards gastric bubble (GEGB) with a sham procedure. The mean cumulative change in the body mass index (BMI, kg/m²) at 12 weeks was as follows: Bubble versus sham -3.1, sham versus bubble -2.3, bubble versus bubble -2.9; at 24 weeks bubble versus sham -3.1, sham versus bubble -3.0 and bubble versus bubble -3.3.<BR/>Although weight loss occurred more consistently in patients with the GEGB, there were no significant differences between any of the three groups at 12 or 24 weeks with respect to weight loss or change in BMI. The major part of the weight loss noted during this study occurred during the first 12-week period, irrespective of therapy.</P>
<P>In the Geliebter trial there was a statically significant weight loss in the groups who used a 1000 kcal/day diet.</P>
<P>The Hogan study compared IGB versus a sham procedure. Weight loss was practically the same in both groups at the first three months (IGB 8.5 kg, sham 8.0 kg).</P>
<P>In the Lindor study the comparison groups were insertion of an intragastric balloon and sham procedures (one patient with balloon treatment withdrew from the study). Weight loss at two or three months in the conventional therapy group averaged 2.8 kg, in the balloon-treated group the mean weight loss was 5.8 kg (P &gt; 0.15).<BR/>Data from two studies (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>; <LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>) could be pooled but demonstrated substantial heterogeneity (I<SUP>2</SUP> = 89.5%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intragastric balloon versus no treatment (Geliebter 1990)</HEADING>
<P>The IGB group lost 3.2 kg (SD 0.9) in comparison to the control group which gained 0.6 kg (SD 0.5).</P>
<P>

</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intragastric balloon versus intragastric balloon plus diet (Geliebter 1990)</HEADING>
<P>The IGB only group lost 3.2 kg (SD 0.9) and the IGB plus diet group lost 5.1 kg (SD 1.0).</P>
<P>

</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intragastric balloon plus diet versus diet only (Geliebter 1990; Mathus-Vliegen 1990; Mathus-Vliegen 2005; Meshkinpour 1988; Ramhamdany 1989; Rigaud 1994)</HEADING>
<P>The trial by Geliebter investigated IGB and diet (group 2) showing a weight loss of 5.1 kg (SD 1.0) versus diet only (group 3) demonstrating a weight loss of 6.9 kg (SD 1.4).</P>
<P>In the Mathus-Vliegen 1990 study, the patients were matched by sex and weight and were randomly divided into four groups. No statistical significant differences in weight loss were revealed.</P>
<P>In the Mathus-Vliegen 2005 study no statistically significant differences in weight loss could be demonstrated. IGB patients lost significantly more weight (15.4 kg) than participants undergoing sham treatment (11.6 kg).</P>
<P>The Meshkinpour trial found that weight loss was significantly greater only during the first and second 2-weeks evaluation periods. This difference, however, disappeared after the four weeks of treatment.</P>
<P>In the Ramhamdany study there was a significantly greater weight loss in the IGB group (mean weight loss 7.3 kg (SD 6.1)) compared with the sham/diet only group (mean weight loss 3.3 kg (SD 3.9)). Weight loss was not maintained in all patients after balloon removal.</P>
<P>In the Rigaud study the cumulative weight loss was 8.6 kg in the IGB plus diet compared to 9.1 kg in the sham procedure plus diet group.</P>
<P>Data from five of the six studies could be pooled statistically but demonstrated substantial heterogeneity (I<SUP>2</SUP> = 91.7%).</P>
<P>

</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Complications</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Minor complications</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Gastric ulcers</HEADING>
<P>Meta-analysis of six studies (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>; <LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>; <LINK REF="STD-Hogan-1989" TYPE="STUDY">Hogan 1989</LINK>; <LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-1990" TYPE="STUDY">Mathus-Vliegen 1990</LINK>; <LINK REF="STD-Meshkinpour-1988" TYPE="STUDY">Meshkinpour 1988</LINK>) demonstrated an increased relative risk of 4.91 (95% CI 1.57 to 15.35) for gastric ulcers following IGB treatment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Gastric erosions </HEADING>
<P>Meta-analysis of six studies (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>; <LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>; <LINK REF="STD-Hogan-1989" TYPE="STUDY">Hogan 1989</LINK>; <LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-1990" TYPE="STUDY">Mathus-Vliegen 1990</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-2005" TYPE="STUDY">Mathus-Vliegen 2005</LINK>) revealed an increased relative risk of 9.78 (95% CI 3.87 to 24.69) for gastric erosions following IGB therapy.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Abdominal pain </HEADING>
<P>Pooling of data from four studies (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>; <LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>; <LINK REF="STD-Meshkinpour-1988" TYPE="STUDY">Meshkinpour 1988</LINK>; <LINK REF="STD-Ramhamdany-1989" TYPE="STUDY">Ramhamdany 1989</LINK>) illustrated an increased relative risk of 14.00 (95% CI 3.45 to 56.74) for abdominal pain following IGB placement.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Vomiting</HEADING>
<P>Data from two studies (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>; <LINK REF="STD-Ramhamdany-1989" TYPE="STUDY">Ramhamdany 1989</LINK>) did not indicate a statistically significant difference of pooled relative risks for vomiting.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Major complications</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Deflation and migration of the balloon</HEADING>
<P>In two studies (<LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>, <LINK REF="STD-Meshkinpour-1988" TYPE="STUDY">Meshkinpour 1988</LINK>) there was no statistically significant difference between the interventions. These studies used the Garren-Edwards intra-gastric balloon technique.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Obstruction of the small intestine </HEADING>
<P>One study (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>) reported data on small bowel obstruction. Three out of 90 participants in the IGB group and none in the control group suffered from this complication.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Mallory-Weiss syndrome</HEADING>
<P>One study (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>) evaluated the occurrence of Mallory-Weiss syndrome with 10 out of 90 participants in the IGB group and none in the control group being diagnosed with this condition.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Oesophageal laceration</HEADING>
<P>In a single study (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>) only one patient in the IGB group versus none in the control group suffered from oesophageal laceration.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-11-10 11:18:59 +0100" MODIFIED_BY="Gudrun Paletta">
<SUMMARY_OF_RESULTS MODIFIED="2008-11-10 11:18:59 +0100" MODIFIED_BY="Gudrun Paletta">
<SUBSECTION>
<HEADING LEVEL="3">Intragastric balloon versus diet</HEADING>
<P>Information from the available studies suggests little benefit if any from treatment with an intragastric balloon (IGB) but higher rates of minor and major complications (mainly spontaneous deflation of the Garren-Edwards balloon). Additionally, there is a tendency of the patients in gaining weight after removal of the balloon, while the diet group tended to continue losing weight.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intragastric balloon versus no treatment</HEADING>
<P>A randomised controlled trial with a high risk of bias (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>) suggests that IGB can prompt little loss of weight within three months of use, although the rate of weight loss decreased after the first month.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intragastric balloon versus intragastric balloon plus diet</HEADING>
<P>Only one randomised controlled trial with a high risk of bias (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>) describes a small positive correlation between the initial weight and the change of weight observed in the IGB group. The similar positive correlation in the IGB plus diet group suggests that this weight loss was due to diet adherence facilitated by the fullness of the balloon. If only the diet had been the main responsible factor, the correlation would have been negative as described in the diet only group. The low motivation for diet was partly reflected by the frequency of the dietetic sessions, and that perhaps explains why the group balloon plus diet did not lose more weight than those receiving diet alone. </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intragastric balloon plus diet versus diet only</HEADING>
<P>No definite conclusions can be drawn due to substantial heterogeneity between trials. Relevant differences between the two therapeutic approaches were not detectable.</P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2008-11-10 11:18:26 +0100" MODIFIED_BY="Gudrun Paletta">
<P>The majority of the individuals included in the trials were women ranging from 14 to 64 years, showing variable degrees of obesity. However, the potential benefits of weight loss by IGB did not show a gender correlation.</P>
</APPLICABILITY_OF_FINDINGS>
<POTENTIAL_BIASES MODIFIED="2008-11-10 11:18:42 +0100" MODIFIED_BY="Gudrun Paletta">
<P>Only a third of the analysed studies revealed a low risk of bas (<LINK REF="STD-Benjamin-1988" TYPE="STUDY">Benjamin 1988</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-2005" TYPE="STUDY">Mathus-Vliegen 2005</LINK>; <LINK REF="STD-Ramhamdany-1989" TYPE="STUDY">Ramhamdany 1989</LINK>), five a moderate risk of bias (<LINK REF="STD-Hogan-1989" TYPE="STUDY">Hogan 1989</LINK>; <LINK REF="STD-Lindor-1987" TYPE="STUDY">Lindor 1987</LINK>; <LINK REF="STD-Mathus_x002d_Vliegen-1990" TYPE="STUDY">Mathus-Vliegen 1990</LINK>; <LINK REF="STD-Meshkinpour-1988" TYPE="STUDY">Meshkinpour 1988</LINK>; <LINK REF="STD-Rigaud-1994" TYPE="STUDY">Rigaud 1994</LINK>) and one was associated with a high risk of bias (<LINK REF="STD-Geliebter-1990" TYPE="STUDY">Geliebter 1990</LINK>).<BR/>An important issue about the balloons used in the management of the weight loss, possibly contributing to heterogeneity were the diverse kinds as well as the differences between the volumes utilized.</P>
</POTENTIAL_BIASES>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>Heterogeneous and partially incomplete data do not permit us to conclude that the intragastric balloon (IGB) is more effective than conventional treatment for weight loss in obesity. However, a co-adjuvant factor described by some authors in the loss and maintenance of weight was the motivation and encouragement to changes in eating habits, through a well-organized diet and programs of behaviour modification. Despite little additional benefit of IGB for weight loss, the cost of this intervention in comparison to a program of eating and behaviour modification should be considered. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Good quality randomised controlled trials especially comparing IGB versus diet and IGB plus diet versus diet only in association with changes in behaviour are necessary. Follow-up should be at least one year and trials should report data on costs, quality of life and co-morbidities, as well as describe weight alterations in terms of body mass index (kg/m<SUP>2</SUP>) or percentage weight loss.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We would like to thank the Brazilian Cochrane Centre, The Federal University of São Paulo and The Faculdade de Medicina de Petrópolis. <U> <BR/>
</U>
</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-11-10 10:54:54 +0100" MODIFIED_BY="Gudrun Paletta">
<P>MARCOS FERNANDES: protocol development, selection of studies, quality assessment, data extraction, data analysis, review development</P>
<P>ÁLVARO NAGIB ATALLAH: protocol development, selection of studies, quality assessment, data extraction, data analysis, review development</P>
<P>BERNARDO G. O. SOARES: protocol development, selection of studies, quality assessment, data extraction, data analysis, review development</P>
<P>SACONATO HUMBERTO: selection of studies, quality assessment, data extraction, data analysis, review development</P>
<P>SANDRA M. GUIMARÃES: selection of studies, data extraction</P>
<P>DÉLCIO MATOS: selection of studies, data analysis, review development</P>
<P>LARISSA C. MONTEIRO: selection of studies, data extraction</P>
<P>BERND RICHTER: quality assessment, data analysis, review development</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-10-23 10:56:56 +0200" MODIFIED_BY="Gudrun Paletta">
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Benjamin-1988" NAME="Benjamin 1988" YEAR="1988">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Benjamin SB</AU>
<TI>Double-blind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity</TI>
<SO>Gastroenterology</SO>
<YR>1988</YR>
<VL>95(3)</VL>
<PG>581-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="3294079"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Geliebter-1990" NAME="Geliebter 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Geliebter A</AU>
<TI>Clinical trial of silicone-rubber gastric balloon to treat obesity</TI>
<SO>International Journey of Obesity</SO>
<YR>1991</YR>
<VL>15</VL>
<PG>259-66</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2071316"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hogan-1989" NAME="Hogan 1989" YEAR="1989">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hogan RB</AU>
<TI>A double-blind, randomized, sham-controled trial of the gastric bubble for obesity</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1989</YR>
<VL>35</VL>
<PG>381-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2792672"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindor-1987" NAME="Lindor 1987" YEAR="1987">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lindor KD</AU>
<TI>Intragastric balloos in comparison with standart therapy for obesity - A randomized, double-blind trial</TI>
<SO>Mayo Clinic proceedings. Mayo Clinic</SO>
<YR>1987</YR>
<VL>62</VL>
<PG>992-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="3312857"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mathus_x002d_Vliegen-1990" NAME="Mathus-Vliegen 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mathus-Vliegen EM</AU>
<TI>Intragastric balloon in treatment of super-morbid obesity</TI>
<SO>Gastroenterology</SO>
<YR>1990</YR>
<VL>99</VL>
<PG>362-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2194894"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mathus_x002d_Vliegen-2005" NAME="Mathus-Vliegen 2005" YEAR="2005">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mathus-Vliegen E</AU>
<TI>Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1 year balloon treatment followed by a 1 year balloon-free follow-up</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2005</YR>
<VL>61</VL>
<PG>19-27</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="15672051"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meshkinpour-1988" NAME="Meshkinpour 1988" YEAR="1988">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Meshkinpour H</AU>
<TI>Effect of gastric bubble as a weight reduction device: A controlled, crossover study</TI>
<SO>Gastroenterology</SO>
<YR>1988</YR>
<VL>95</VL>
<PG>589-92</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="3294080"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramhamdany-1989" NAME="Ramhamdany 1989" YEAR="1989">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ramhamdany EM</AU>
<TI>Effect of the gastric balloon versus sham procedure on weight loss in obese subjects</TI>
<SO>Gut</SO>
<YR>1989</YR>
<VL>30</VL>
<PG>1054-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2767500"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rigaud-1994" NAME="Rigaud 1994" YEAR="1994">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rigaud D</AU>
<TI>Gastric distension, hunger and energy intake after balloon implantation in severre obesity</TI>
<SO>International Journal of Obesity</SO>
<YR>1995</YR>
<VL>19</VL>
<PG>489-95</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="8520639"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Al_x002d_Momen-2005" NAME="Al-Momen 2005" YEAR="2005">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Al-Momen A</AU>
<TI>Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy</TI>
<SO>Obesity Surgery</SO>
<YR>2005</YR>
<VL>15</VL>
<PG>101-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="15760507"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baratta-1999" NAME="Baratta 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Baratta R</AU>
<TI>Adjustable Silicone Gastric Banding and Intragastric Balloon: Our experience.</TI>
<SO>1st International Symposium on Laparoscopic Obesity Surgery</SO>
<YR>March 1999</YR>
<CY>Naples, Italy</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barkin-1988" NAME="Barkin 1988" YEAR="1988">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Barkin JS</AU>
<TI>Effects of gastric bubble implant on weght change with and without compliance with a behavior modification program</TI>
<SO>Am J Gastroenterol</SO>
<YR>1988</YR>
<VL>83</VL>
<PG>930-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="3414646"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Benjamin-1988b" NAME="Benjamin 1988b" YEAR="1988">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Benjamin SB</AU>
<TI>Small bowel obstruction and the Garren-Edwards gastric bubble: an iatrogenic bezoar</TI>
<SO>Gastrointest Endosc.</SO>
<YR>1988</YR>
<VL>34</VL>
<PG>463-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="3234683"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Biondi-1999" NAME="Biondi 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Biondi A</AU>
<TI>Laparoscopic Adjustable Esophagogastric Banding Vs Intragastric Balloon: A Preliminary Experience</TI>
<SO>1st International Symposium on Laparoscopic Obesity Surgery</SO>
<YR>March 1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brown-1988" NAME="Brown 1988" YEAR="1988">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Brown TH</AU>
<TI>The effect of an intragastric balloon on weght loss, gastric acid secretion, and serum peptide levels.</TI>
<SO>Am Surg.</SO>
<YR>1988</YR>
<VL>54</VL>
<PG>109-12</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="3341643"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Busetto-2004" NAME="Busetto 2004" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Busetto L</AU>
<TI>Preoperative weight loss by intragastric balloon in superobese patients treated with laparoscopic gastric banding: a case-control study</TI>
<SO>Obesity Surgery</SO>
<YR>2004</YR>
<VL>14</VL>
<PG>671-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="15186637"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Butterwegge-1993" NAME="Butterwegge 1993" YEAR="1993">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Butterwegge M</AU>
<TI>Ileus in pregnancy induced by a gastric balloon</TI>
<SO>Zentralcl Gynakol</SO>
<YR>1993</YR>
<VL>115</VL>
<PG>238-40</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="8517084"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carim-2005" NAME="Carim 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Carim JAV</AU>
<TI>Avaliação dos resultados com a utilização do balão intragástrico (BIB) no controle da obesidade</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2005</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coelho-2003" NAME="Coelho 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Coelho E</AU>
<TI>Protocolo fisioterápico da Cirurgia Bariátrica</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2003</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Conti-1988" NAME="Conti 1988" YEAR="1988">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Conti PS</AU>
<TI>Bowel obstruction caused by gastric balloons</TI>
<SO>Am J of Roentgenology</SO>
<YR>1988</YR>
<VL>151</VL>
<PG>313-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="1988181555"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cormillot-2002" NAME="Cormillot 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Cormillot A</AU>
<TI>Intragastric balloon implant as a mean of weight reduction in a multidisciplinary, specialized network for the treatment of obese patients</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Darvich-2005" NAME="Darvich 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Darvich I</AU>
<TI>Experiencia inicial con el uso del balón intragastrico (BIG) para la reducción de peso</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2005</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Luca-1999" NAME="De Luca 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>De Luca M</AU>
<TI>Bioenterics Intragastric Balloon (BIB) System: Results of the follow-up and criteria of selection of the patients.</TI>
<SO>1st International Symposium on Laparoscopic Obesity Surgery</SO>
<YR>1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Waele-2000" NAME="De Waele 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Waele B b</AU>
<TI>Intragastric Balloon for preoperative weight reduction</TI>
<SO>Obesity Surgery</SO>
<YR>2000</YR>
<VL>10</VL>
<PG>58-60</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="10715647"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Waele-2001" NAME="De Waele 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>De Waele B</AU>
<TI>Endoscopic volume adjustment of intragastric balloons for intolerance.</TI>
<SO>Obes Surg</SO>
<YR>2001</YR>
<VL>11</VL>
<PG>223-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="11355031"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Doldi-2000" NAME="Doldi 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Doldi SB</AU>
<TI>Intragastric Balloon in obese patients</TI>
<SO>Obesity Surgery</SO>
<YR>2000</YR>
<VL>10</VL>
<PG>578-81</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="11175969"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Doldi-2002" NAME="Doldi 2002" YEAR="2002">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Doldi SB</AU>
<TI>Treatment of morbid obesity with intragastric balloon in association with diet</TI>
<SO>Obesity Surgery</SO>
<YR>2002</YR>
<VL>12</VL>
<PG>583-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="12194556"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Durrans-1989" NAME="Durrans 1989" YEAR="1989">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Durrans D</AU>
<TI>Comparison of weight loss with short term dietary and intragastric balloon treatment</TI>
<SO>Gut</SO>
<YR>1989</YR>
<VL>30</VL>
<PG>565-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2731747"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Evans-2001" NAME="Evans 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Evans JD</AU>
<TI>Intragastric balloon in the treatment of patients with morbid obesity</TI>
<SO>Br J Surg</SO>
<YR>2001</YR>
<VL>88</VL>
<PG>1245-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="11531875"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eynden-2001" NAME="Eynden 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Eynden FV</AU>
<TI>Small intestine gastric balloon impaction treated by laparoscopic surgery</TI>
<SO>Obes Surg</SO>
<YR>2001</YR>
<VL>11</VL>
<PG>646-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="11594113"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fleisher-1987" NAME="Fleisher 1987" YEAR="1987">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fleisher A</AU>
<TI>Jejunal entrapment of a gastric balloon</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1987</YR>
<VL>257</VL>
<PG>930</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="1987091882"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Forestieri-1999" NAME="Forestieri 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Forestieri E</AU>
<TI>BioEnterics Intragastric Balloon (BIB): The Italian experience</TI>
<SO>Obesity Surgery</SO>
<YR>1999</YR>
<VL>9</VL>
<PG>353</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Galloro-1999" NAME="Galloro 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Galloro G</AU>
<TI>Bioenterics Intragastric Balloon (BIB): Endoscopic Option in the treatment of Morbid Obesity</TI>
<SO>1st International Symposium on Laparoscopic Obesity Surgery</SO>
<YR>1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Galloro-1999b" NAME="Galloro 1999b" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Galloro G</AU>
<TI>Preliminary endoscopic technical report of a new silicone intragastric balloon in the treatment of morbid obesity</TI>
<SO>Obes Surg</SO>
<YR>1999</YR>
<VL>9</VL>
<PG>68-71</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="10065589"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gau-1989b" NAME="Gau 1989b" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Gau MD</AU>
<TI>Clinical Trial Protocol SIB-001 Silicone Intragastric Balloon: Final Report.</TI>
<SO>INAMED</SO>
<YR>March 1989</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Geliebter-1985" NAME="Geliebter 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Geliebter A b</AU>
<TI>Intragastric balloon induced rreduction of test meal intake</TI>
<SO>Fed. Proc</SO>
<YR>1985</YR>
<VL>44</VL>
<NO>5</NO>
<PG>No-6386</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Geliebter-1990b" NAME="Geliebter 1990b" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Geliebter A</AU>
<TI>Gastric balloon to treat obesity: a double-blind study in nondeting subjects</TI>
<SO>American Journal Clinical Nutrition</SO>
<YR>1190</YR>
<VL>51</VL>
<PG>584-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2181857"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Genco-2002" NAME="Genco 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Genco A</AU>
<TI>Intragastric balloon for the treatment of obesity</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heraief-1989" NAME="Heraief 1989" YEAR="1989">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Heraief E</AU>
<TI>The intragastric balloon: a logical and attractive idea, but probably ineffective</TI>
<SO>Ther Umsch.</SO>
<YR>1989</YR>
<VL>46</VL>
<PG>329-33</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2741134"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Herzog-1988" NAME="Herzog 1988" YEAR="1988">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Herzog P</AU>
<TI>Endoscopic implantation of a gastric balloon - a method of weight reduction with few complications?</TI>
<SO>Dutch Med Wochenschr.</SO>
<YR>1988</YR>
<VL>113</VL>
<PG>1064-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="3383757"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hodson-2001" NAME="Hodson 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hodson RM</AU>
<TI>Management of obesity with the new intragastric balloon</TI>
<SO>Obes Surg</SO>
<YR>2001</YR>
<VL>11</VL>
<PG>327-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="11433910"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ingelmo-2002" NAME="Ingelmo 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Ingelmo JC</AU>
<TI>Migration of intragastric balloon and disease of Chron: a case report</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2000" NAME="Kim 2000" YEAR="2000">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kim WY</AU>
<TI>Large bowel impaction by BioEnterics Intragastric Balloon (BIB) necessitating surgical intervention</TI>
<SO>Ann R Coll Surg Engl</SO>
<YR>2000</YR>
<VL>82</VL>
<PG>202-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="10858686"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kirby-1990" NAME="Kirby 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kirby DF</AU>
<TI>A prospective assesment of the Garren-Edwards Gastric Bubble and bariatric surgery in the treatment of morbid obesity.</TI>
<SO>Am Surgery</SO>
<YR>1990</YR>
<VL>56</VL>
<PG>575-80</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2221603"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kobler-1988" NAME="Kobler 1988" YEAR="1988">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kobler E</AU>
<TI>Morbid obesity. Our results with the appetite-depressing stomach balloon</TI>
<SO>Schweiz Med Wochenschr</SO>
<YR>1988</YR>
<VL>118</VL>
<PG>118-21</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="3344416"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kral-1988" NAME="Kral 1988" YEAR="1988">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kral JG</AU>
<TI>Gastric balloons: a plea for sanity in the midst of balloonacy</TI>
<SO>Gastroenterology</SO>
<YR>1988</YR>
<VL>95</VL>
<PG>213-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="3371617"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kramer-1989" NAME="Kramer 1989" YEAR="1989">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kramer FM</AU>
<TI>Limited weight losses with a gastric balloon</TI>
<SO>Arch Intern Med.</SO>
<YR>1989</YR>
<VL>149</VL>
<PG>411-3</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2916886"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laurent-2001" NAME="Laurent 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Laurent B</AU>
<TI>Covered gastric perfuration by the Bioenterics Intragastric Balloon</TI>
<SO>J Clin Gastroenterol.</SO>
<YR>2001</YR>
<VL>33</VL>
<PG>344-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="11588557"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laurent_x002d_Jaccard-1990" NAME="Laurent-Jaccard 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Laurent-Jaccard A</AU>
<TI>Obesity: indications for surgery</TI>
<SO>Schweiz Rundsch Med Prax.</SO>
<YR>1990</YR>
<VL>79</VL>
<PG>854-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2374852"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lieber-1987" NAME="Lieber 1987" YEAR="1987">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lieber CP</AU>
<TI>Temporary intervention: dental spliting and the intragastric bubble</TI>
<SO>Gastroenterol Clin North Am.</SO>
<YR>1987</YR>
<VL>16</VL>
<PG>451-60</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="3325426"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Loffredo-2001" NAME="Loffredo 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Loffredo A</AU>
<TI>three years experience with the new intragastric balloon and a preoperative test for siccess with restrictive surgery</TI>
<SO>Obes Surg</SO>
<YR>2001</YR>
<VL>11</VL>
<PG>330-3</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="11433911"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luppa-1999" NAME="Luppa 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Luppa A</AU>
<TI>Short-term complications in patients treated with BIB and/or Lap-band for Morbid Obesity</TI>
<SO>1st International Symposium on Laparoscopic Obesity Surgery</SO>
<YR>March 1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marchesini-2001" NAME="Marchesini 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Marchesini JCD</AU>
<TI>Complications of Intragastric Balloon</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marshall-1990" NAME="Marshall 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Marshall JB</AU>
<TI>a prospective multicenter clinical trial of the Taylor Intragastric Balloon for the treatment of morbid obesity.</TI>
<SO>Am J Gastroenterol.</SO>
<YR>1990</YR>
<VL>85</VL>
<PG>833-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2196784"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mathus_x002d_Vliegen-1990b" NAME="Mathus-Vliegen 1990b" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mathus-Vliegen EM</AU>
<TI>Intragastric Balloons for morbid obesity: results, patient tolerance and balloon life span.</TI>
<SO>British Journal Surgery</SO>
<YR>1990</YR>
<VL>77</VL>
<PG>76-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2302519"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mathus_x002d_Vliegen-1996" NAME="Mathus-Vliegen 1996" YEAR="1996">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mathus-Vliegen LM</AU>
<TI>Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension.</TI>
<SO>Eur J Gastroenterol</SO>
<YR>1996</YR>
<VL>8</VL>
<PG>635-40</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="8853250"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mathus_x002d_Vliegen-1997" NAME="Mathus-Vliegen 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mathus-Vliegen E c</AU>
<TI>Efficacy of the BioEnterics Intragastric Balloon treatment in a prospective 2 years follow-up study</TI>
<SO>8th European Congress on Obesity</SO>
<YR>August 1997</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mathus_x002d_Vliegen-1997b" NAME="Mathus-Vliegen 1997b" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mathus-Vliegen E d</AU>
<TI>Tolerance and safety of BioEnterics Intragastric Balloons</TI>
<SO>8th European Congress on Obesity</SO>
<YR>August 1997</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mathus_x002d_Vliegen-2002" NAME="Mathus-Vliegen 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mathus-Vliegen EM</AU>
<TI>Gastroesophageal reflux in obese subjects: influence of overweight, weight loss and chronic gastric balloon distension</TI>
<SO>Scand Journal Gastroenterology</SO>
<YR>2002</YR>
<VL>37</VL>
<PG>1246-52</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="12465720"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mathus_x002d_Vliegen-2003" NAME="Mathus-Vliegen 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mathus-Vliegen EM</AU>
<TI>Los function and obesity: the impact of untreated obesity, weight loss, and chronic gastric balloon distension</TI>
<SO>Digestion</SO>
<YR>2003</YR>
<VL>68</VL>
<PG>161-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="14671423"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miguel-2004" NAME="Miguel 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Miguel PR</AU>
<TI>Análise dos resultados obtidos com a colocação do balão intragastrico BIB, em 169 pacientes no peródo de 01/2001 a 08/2004</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2004</YR>
<VL>9</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Milone-2005" NAME="Milone 2005" YEAR="2005">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Milone L</AU>
<TI>Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI&gt; or = 50)</TI>
<SO>Obesity Surgery</SO>
<YR>2005</YR>
<VL>15</VL>
<PG>612-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="15946449"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mion-2005" NAME="Mion 2005" YEAR="2005">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mion F</AU>
<TI>Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients</TI>
<SO>Obesity Surgery</SO>
<YR>2005</YR>
<VL>15</VL>
<PG>510-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="15946431"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mirich-1989" NAME="Mirich 1989" YEAR="1989">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mirich DR</AU>
<TI>Percutaneous deflation of a gastric balloon: Technical note</TI>
<SO>Cardiovascular and Interventional Radiology</SO>
<YR>1989</YR>
<VL>12</VL>
<PG>164-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="1989218479"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neves-2003" NAME="Neves 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Neves LF</AU>
<TI>Obstrução intestinal por balão intragástrico caseiro</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2003</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pasquali-1990" NAME="Pasquali 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pasquali R</AU>
<TI>Mechanisms of action of the intragastric balloon in obesity: effects on hunger and satiety.</TI>
<SO>Appetite</SO>
<YR>1990</YR>
<VL>15</VL>
<PG>3-11</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2241140"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perez_x002d_Cuadrado-1993" NAME="Perez-Cuadrado 1993" YEAR="1993">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Perez-Cuadrado E</AU>
<TI>Complications of the intragastric balloon prothesis</TI>
<SO>REV Esp Enferm Dig.</SO>
<YR>1993</YR>
<VL>84</VL>
<PG>291-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="8305255"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pizani-2003" NAME="Pizani 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pizani CE</AU>
<TI>Utilização do balão intragástrico (BIB) no preparo pré-operatório de pacientes superobesos</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2003</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pizani-2005" NAME="Pizani 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Pizani CE</AU>
<TI>Utilização do balão intragástrico em adolescentes obesos</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2005</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pretolesi-2001" NAME="Pretolesi 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pretolesi F</AU>
<TI>Intragastric balloon for morbid obesity causing chronic gastric dilatation.</TI>
<SO>Eur Radiol.</SO>
<YR>2001</YR>
<VL>11</VL>
<PG>588-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="11354752"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roman-2004" NAME="Roman 2004" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Roman S</AU>
<TI>Intragastric balloon for "non-morbid" obesity: a retrospective evaluation of tolerance and efficacy</TI>
<SO>Obesity Surgery</SO>
<YR>2004</YR>
<VL>14</VL>
<PG>539-44</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="15130235"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roman-2005" NAME="Roman 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Roman S</AU>
<TI>Results and follow-up using the intragastric balloon for the treatment of non morbid obese patients: experience in 176 patients</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rubio-1988" NAME="Rubio 1988" YEAR="1988">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rubio PA</AU>
<TI>Esophageal rupture secondary to passage of a gastric bubble for weight control</TI>
<SO>Arch Surg.</SO>
<YR>1988</YR>
<VL>123</VL>
<PG>394-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="3341920"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sallet-2002" NAME="Sallet 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Sallet JA</AU>
<TI>Utilization of the BIB system in pre-operative preparation for super obese patients presenting high surgical risk</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sallet-2004" NAME="Sallet 2004" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sallet JA</AU>
<TI>Brazilian multicenter study of the intragastric balloon</TI>
<SO>Obesity Surgery</SO>
<YR>2004</YR>
<VL>14</VL>
<PG>991-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="15329191"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scheiderman-1988b" NAME="Scheiderman 1988b" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scheiderman MD</AU>
<TI>Clinical Trial Protocol SIB-001 Silicone Intragastric Balloon: Final Report.</TI>
<SO>INAMED</SO>
<YR>October 1988</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Siardi-1990" NAME="Siardi 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Siardi C</AU>
<TI>Treatment of morbid obesity with gastric balloon</TI>
<SO>Minerva Dietol Gastroenterol.</SO>
<YR>1990</YR>
<VL>36</VL>
<PG>13-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2336162"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tosetti-1996" NAME="Tosetti 1996" YEAR="1996">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tosetti C</AU>
<TI>Gastric emptying of solids in morbid obesity</TI>
<SO>Int J Obes Relat Metab Disord.</SO>
<YR>1996</YR>
<VL>20</VL>
<PG>200-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="8653139"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Totte-2001" NAME="Totte 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Totte E</AU>
<TI>Weight reduction by means of intragastric device: experience with the bioenterics intragastric balloon</TI>
<SO>Obesity Surgery</SO>
<YR>2001</YR>
<VL>11</VL>
<PG>519-23</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="11501367"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Treacy-1997" NAME="Treacy 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Treacy PJ</AU>
<TI>Use of the Intragastric Balloon for short term weight loss in patients with severe obesity</TI>
<SO>Annual meeting of the Royal Australian College of Surgeons</SO>
<YR>May 1997</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Valad_x00e3_o-2003" NAME="Valadão 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Valadão JA</AU>
<TI>Tratamento da obesidade mórbida pelo balão intragástrico no Hospital São Domingos</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2003</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Hee-2003" NAME="Van Hee 2003" YEAR="2003">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Van Hee R</AU>
<TI>Use of anti-emetics after intragastric balloonn placement: experience with three different drug treatments</TI>
<SO>Obesity Surgery</SO>
<YR>2003</YR>
<VL>13</VL>
<PG>932-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="14738685"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vandenplas-1999" NAME="Vandenplas 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Vandenplas Y</AU>
<TI>Intragastric balloons in adolescents with morbid obesity</TI>
<SO>Eur J Gastroenterol</SO>
<YR>1999</YR>
<VL>11</VL>
<PG>243-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="10333195"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Velchik-1989" NAME="Velchik 1989" YEAR="1989">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Velchik MG</AU>
<TI>Effect of the Garren-Edqards gastric bubble on gastric emptying</TI>
<SO>J Nucl Med.</SO>
<YR>1989</YR>
<VL>30</VL>
<PG>692-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2715831"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wahlen-2001" NAME="Wahlen 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wahlen CH</AU>
<TI>The BioEnterics Intragastric Balloon (BIB): how to use it.</TI>
<SO>Obes Surg</SO>
<YR>2001</YR>
<VL>11</VL>
<PG>524-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="11501368"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiner-1998" NAME="Weiner 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weiner R c</AU>
<TI>Pre-surgical treatment of extremely obese patients with the Intragastric Balloon</TI>
<SO>Obesity Surgery</SO>
<YR>1998</YR>
<VL>8</VL>
<PG>367-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiner-1999" NAME="Weiner 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Weiner R</AU>
<TI>Preparation of extremely obese patients for laparoscopic gastric banding by gastric balloon therapy</TI>
<SO>Obesity Surgery</SO>
<YR>1999</YR>
<VL>9</VL>
<PG>261-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="10484312"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiner-2002" NAME="Weiner 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Weiner S</AU>
<TI>Preliminary data in quality of life after weight loss surgery in a prospective randomised study comparing intragastric balloon, gastric bypass, gastric banding and BPD-DS</TI>
<SO>Boletim da Sociedade Brasileira de Cirurgia Bariátrica</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-10-23 10:56:56 +0200" MODIFIED_BY="Gudrun Paletta">
<ADDITIONAL_REFERENCES MODIFIED="2008-10-23 10:56:56 +0200" MODIFIED_BY="Gudrun Paletta">
<REFERENCE ID="REF-Adami-1995" NAME="Adami 1995" TYPE="JOURNAL_ARTICLE">
<AU>Adami GF, Gandolfo P, Bauer B</AU>
<TI>Binge eating in massively obese patients undergoing bariatric surgery</TI>
<SO>International Journal of Eating Disorders</SO>
<YR>1995</YR>
<VL>17</VL>
<PG>45-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Agras-1993" NAME="Agras 1993" TYPE="BOOK_SECTION">
<AU>Agras WS</AU>
<TI>Short-term psychological treatments for binge eating</TI>
<SO>Binge eating</SO>
<YR>1993</YR>
<PG>270-86</PG>
<ED>Fairburn CG, Wilson GT</ED>
<PB>Guilford Press</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Alvarez-1998" NAME="Alvarez 1998" TYPE="JOURNAL_ARTICLE">
<AU>Alvarez Cordero R</AU>
<TI>Treatment of clinically severe obesity, a public health problem: introduction</TI>
<SO>World Journal of Surgery</SO>
<YR>1998</YR>
<VL>22</VL>
<PG>905-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ashy-1998" NAME="Ashy 1998" TYPE="JOURNAL_ARTICLE">
<AU>Ashy ARA, Merdad AA</AU>
<TI>A prospective study comparing vertical banded gastroplasty versus laparoscopic adjustable gastric banding in the treatment of morbid and super-obesity</TI>
<SO>International Surgery</SO>
<YR>1998</YR>
<VL>83</VL>
<PG>108-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Behrns-1993" NAME="Behrns 1993" TYPE="JOURNAL_ARTICLE">
<AU>Behrns KE, Smith CD</AU>
<TI>Reoperative bariatric surgery: lessons learned to improve patient selection and results</TI>
<SO>Annals of Surgery</SO>
<YR>1993</YR>
<VL>218</VL>
<PG>646-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Belachew-1993" NAME="Belachew 1993" TYPE="JOURNAL_ARTICLE">
<AU>Belachew M, Jacquet P, Lardinois F, Karler C</AU>
<TI>Vertical banded gastroplasty versus adjustable silicone gastric band in the treatment of morbid obesity: a preliminary report</TI>
<SO>Obesity Surgery</SO>
<YR>1993</YR>
<VL>3</VL>
<PG>275-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Belachew-1998" NAME="Belachew 1998" TYPE="JOURNAL_ARTICLE">
<AU>Belachew M, Legrand M</AU>
<TI>Laparoscopic adjustable banding</TI>
<SO>World Journal of Surgery</SO>
<YR>1998</YR>
<VL>22</VL>
<PG>955-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boman-1998" NAME="Boman 1998" TYPE="JOURNAL_ARTICLE">
<AU>Boman L, Domellellöf L</AU>
<TI>Biliary intestinal bypass in the treatment of obesity: long-term follow-up</TI>
<SO>European Journal of Surgery</SO>
<YR>1998</YR>
<VL>164</VL>
<PG>943-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bray-1985" NAME="Bray 1985" TYPE="JOURNAL_ARTICLE">
<AU>Bray GA</AU>
<TI>Complications of Obesity</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1985</YR>
<VL>103</VL>
<PG>1052-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Buchwald-1984" NAME="Buchwald 1984" TYPE="BOOK_SECTION">
<AU>Buchwald H, Rucker RDJ</AU>
<TI>A History of morbid obesity</TI>
<SO>Advances in Gastrointestinal Surgery</SO>
<YR>1984</YR>
<PG>235-49</PG>
<ED>JS Najariaan, Delaney JP</ED>
<PB>Year Book Medical Publishers</PB>
<CY>Chicago</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Capella-1991" NAME="Capella 1991" TYPE="JOURNAL_ARTICLE">
<AU>Capella RF, Capella J, Mandac H, Nath P</AU>
<TI>Vertical Banded gastroplasty: gastric bypass</TI>
<SO>Obesity Surgery</SO>
<YR>1991</YR>
<VL>1</VL>
<PG>219</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chalmers-1983" NAME="Chalmers 1983" TYPE="JOURNAL_ARTICLE">
<AU>Chalmers TC</AU>
<TI>Bias in treatment assiggnment in controlled clinical trials</TI>
<SO>New England Journal of Medicine</SO>
<YR>1983</YR>
<VL>309</VL>
<PG>1358-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-1960" MODIFIED="2008-10-23 10:56:50 +0200" MODIFIED_BY="Gudrun Paletta" NAME="Cohen 1960" TYPE="JOURNAL_ARTICLE">
<AU>Cohen J</AU>
<TI>A coefficient of agreement for nominal scales</TI>
<SO>Educational and Psychological Measurement</SO>
<YR>1960</YR>
<VL>20</VL>
<PG>37-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Colquitt-2003" NAME="Colquitt 2003" TYPE="COCHRANE_REVIEW">
<AU>Colquitt J, Clegg A, Sidhu M, Royle P</AU>
<TI>Surgery for morbid obesity (Cochrane Review)</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>2</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CRD-1997" NAME="CRD 1997" TYPE="OTHER">
<AU>NHS Centre for Reviews and Dissemination</AU>
<TI>Systematic review of interventions in the treatment and prevention of obesity</TI>
<SO>CDR Report (Centre for Reviews and Dissemination)</SO>
<YR>1997</YR>
<VL>10</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deitel-1998" NAME="Deitel 1998" TYPE="JOURNAL_ARTICLE">
<AU>Deitel M</AU>
<TI>Overview of operations for morbid obesity</TI>
<SO>World Journal of Surgery</SO>
<YR>1998</YR>
<VL>22</VL>
<PG>913-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Erens-1999" NAME="Erens 1999" TYPE="JOURNAL_ARTICLE">
<AU>Erens</AU>
<TO>Health survey for England: Cardiovascular Disease</TO>
<SO>Findings</SO>
<YR>1998;1999</YR>
<VL>1;8</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fobi-1998" NAME="Fobi 1998" TYPE="JOURNAL_ARTICLE">
<AU>Fobi MAL, Lee H</AU>
<TI>Gastric bypass operation for obesity</TI>
<SO>World Journal of Surgery</SO>
<YR>1998</YR>
<VL>22</VL>
<PG>925-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Frandsen-1998" NAME="Frandsen 1998" TYPE="JOURNAL_ARTICLE">
<AU>Frandsen J, Pedersen SB, Richelsen B</AU>
<TI>Long-term follow-up of patients who underwent jejunoileal bypass for morbid obesity</TI>
<SO>European Journal of Surgery</SO>
<YR>1998</YR>
<VL>164</VL>
<PG>281-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Garrido-1998" NAME="Garrido 1998" TYPE="BOOK_SECTION">
<AU>Garrido Jr AB</AU>
<TO>Situações especiais: Tratamento da obesidade mórbida</TO>
<SO>Obesidade</SO>
<YR>1998</YR>
<PG>331-40</PG>
<ED>Halpern A, Matos AGF, Suplicy H, Mancini MC, Zanella MT</ED>
<PB>Lemos</PB>
<CY>São Paulo</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Halpern-1999" NAME="Halpern 1999" TYPE="JOURNAL_ARTICLE">
<AU>Halpern A, Mancini MC</AU>
<TO>Obesidade:Como diagnosticar e tratar</TO>
<SO>Revista brasileira de medicina</SO>
<YR>1999</YR>
<VL>56</VL>
<PG>7-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Harvard-1991" NAME="Harvard 1991" TYPE="JOURNAL_ARTICLE">
<AU>Harvard Medical School</AU>
<TI>Treatment of Obesity</TI>
<YR>1991</YR>
<VL>Nov</VL>
<PG>7-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" MODIFIED="2008-10-23 10:56:56 +0200" MODIFIED_BY="Gudrun Paletta" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1539-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2005" NAME="Higgins 2005" TYPE="COCHRANE_REVIEW">
<AU>Higgins JPT</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>3</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<CY>Chichester ,UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jung-1997" NAME="Jung 1997" TYPE="JOURNAL_ARTICLE">
<AU>Jung RT</AU>
<TI>Obesity as a disease</TI>
<SO>British Medical Bulletin</SO>
<YR>1997</YR>
<VL>53</VL>
<NO>2</NO>
<PG>307-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jung-2000" NAME="Jung 2000" TYPE="BOOK_SECTION">
<AU>Jung RT, Cuschieri A</AU>
<TI>Obese patients</TI>
<SO>Essential Surgical Practice</SO>
<YR>2000</YR>
<VL>1</VL>
<EN>4th</EN>
<ED>Cuschieri A, Steele RJC, Moosa AR</ED>
<PB>Butterworth Heinemann</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kusmak-1989" NAME="Kusmak 1989" TYPE="BOOK_SECTION">
<AU>Kusmak LI</AU>
<TI>Gastric Banding</TI>
<SO>Surgery for the morbity obese patient</SO>
<YR>1989</YR>
<PG>115-59</PG>
<ED>Deitel M</ED>
<PB>Lea &amp; Fabinger</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Manson-1995" NAME="Manson 1995" TYPE="JOURNAL_ARTICLE">
<AU>Manson JE, Willet W</AU>
<TI>Body weight and mortality among women</TI>
<SO>New England Journal of Medicine</SO>
<YR>1995</YR>
<VL>333</VL>
<PG>677-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marceau-1988" NAME="Marceau 1988" TYPE="JOURNAL_ARTICLE">
<AU>Marceau P</AU>
<TI>Biliopancreatic diversion with duodenal switch</TI>
<SO>World Journal of Surgery</SO>
<YR>1988</YR>
<VL>22</VL>
<PG>947-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mason-1967" NAME="Mason 1967" TYPE="JOURNAL_ARTICLE">
<AU>Mason EE, Ito C</AU>
<TI>Gastric bypass in obesity</TI>
<SO>Surgical Clinics of North America</SO>
<YR>1967</YR>
<VL>47</VL>
<NO>60</NO>
<PG>1345-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mason-1982" NAME="Mason 1982" TYPE="JOURNAL_ARTICLE">
<AU>Mason EE</AU>
<TI>Vertical banded gastroplasty for obesity</TI>
<SO>Archives of Surgery</SO>
<YR>1982</YR>
<VL>117</VL>
<PG>701-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mason-1998" NAME="Mason 1998" TYPE="JOURNAL_ARTICLE">
<AU>Mason EE, Doherty C</AU>
<TI>Vertical gastroplasty: evolution of vertical banded gastroplasty</TI>
<SO>World Journal of Surgery</SO>
<YR>1998</YR>
<VL>22</VL>
<PG>919-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mathus-1997" NAME="Mathus 1997" TYPE="CONFERENCE_PROC">
<AU>Mathus-Vliegen EMH</AU>
<SO>Efficacy of bioenterics intragastric balloon treatment in a prospective 2 years follow-up study. Presented at the Eighth European Congress on Obesity; 1997 Aug</SO>
<YR>1997</YR>
<PB>European Congress on Obesity</PB>
<CY>Dublin, Ireland</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-1998" NAME="Moher 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moher D</AU>
<TI>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>352</VL>
<PG>609-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Monteiro-1998" NAME="Monteiro 1998" TYPE="BOOK_SECTION">
<AU>Monteiro CA</AU>
<TI>Obesity</TI>
<TO>Obesidade</TO>
<SO>Epidemiologia da Obesidade</SO>
<YR>1998</YR>
<PG>15-30</PG>
<PB>Editora Lemos</PB>
<CY>São Paulo</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nieben-1982" NAME="Nieben 1982" TYPE="JOURNAL_ARTICLE">
<AU>Nieben OG, Harboe H</AU>
<TI>Intragastric balloon as an artificial bezoar for treatment for obesity</TI>
<SO>The Lancet</SO>
<YR>1982</YR>
<VL>1</VL>
<NO>8265</NO>
<PG>198-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sallet-2001" NAME="Sallet 2001" TYPE="BOOK">
<AU>Sallet JA</AU>
<SO>Balão Intragástrico: Gastroplastia Endoscópica para o tratamento da Obesidade</SO>
<YR>2001</YR>
<PB>Editora Caminho Editorial</PB>
<CY>São Paulo</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<PG>408</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Scopinaro-1979" NAME="Scopinaro 1979" TYPE="JOURNAL_ARTICLE">
<AU>Scopinaro N, Gianetta J, Civarelli D, Bonalumi U, Bachi V</AU>
<TI>Biliopancreatic bypass for obesity: Initial experience in man</TI>
<SO>British Journal of Surgery</SO>
<YR>1979</YR>
<VL>66</VL>
<PG>618-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Scopinaro-1998" NAME="Scopinaro 1998" TYPE="JOURNAL_ARTICLE">
<AU>Scopinaro N, Adami GF, Marinari GM, Traverso E, Camerini G, Baschieri G, Simonelli A</AU>
<TI>Long-term results of biliopancreatic diversion in the treatment of morbid obesity</TI>
<SO>World Journal of Surgery</SO>
<YR>1998</YR>
<VL>22</VL>
<PG>936-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Seidell-1998" NAME="Seidell 1998" TYPE="BOOK_SECTION">
<AU>Seidell JC</AU>
<TI>Epidemiology: Definition and Classification of Obesity</TI>
<SO>Clinical Obesity</SO>
<YR>1998</YR>
<PG>1-17</PG>
<ED>Kopelman PG, Stock KMJ</ED>
<PB>Blackwell Science</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Terra-1997" NAME="Terra 1997" TYPE="JOURNAL_ARTICLE">
<AU>Terra JL</AU>
<TO>Le point de vue du psychiatre sur le traitment de lóbesité morbide par gastroplastie</TO>
<SO>Annales de Chirurgie</SO>
<YR>1997</YR>
<VL>51</VL>
<PG>177-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wittgrove-1996" NAME="Wittgrove 1996" TYPE="JOURNAL_ARTICLE">
<AU>Wittgrove AC, Cirk W, Schubert KR</AU>
<TI>Laparoscpic gastric bypass, Roux-em-y: technique and results in 75 patients with 3-30 month follow-up</TI>
<SO>Obesity Surgery</SO>
<YR>1996</YR>
<VL>6</VL>
<PG>500-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Young-1996" NAME="Young 1996" TYPE="JOURNAL_ARTICLE">
<AU>Young T, Finn L, Hla M, Morgan B, Palta M</AU>
<TI>Snoring as part of a dose-response relationship between sleep-disordered breathing and blood plessure</TI>
<SO>Sleep</SO>
<YR>1996</YR>
<VL>19</VL>
<NO>10</NO>
<PG>202-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zuccaro-2002" NAME="Zuccaro 2002" TYPE="OTHER">
<AU>Zuccaro AM</AU>
<TO>A Endoscopia Digestiva Alta na Obesidade Mórbida</TO>
<SO>http://sobedrj.com.br/boletim.htm</SO>
<YR>(accessed 15 Aug 2002).</YR>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Benjamin-1988">
<CHAR_METHODS>
<P>Design: <BR/>Double/multi center (Virginia &amp; Washington D.C.)<BR/>Follow-up: <BR/>24 weeks<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: <BR/>U.S.A. <BR/>Number: <BR/>Total 90<BR/>Weight (mean): <BR/>30 % above ideal body weight<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>12 weeks:<BR/>Group 1: Balloon X Sham<BR/>Group 2: Sham X Balloon<BR/>Group 3: Balloon X Balloon<BR/>12 wks Balloon sham Balloon<BR/>12 wks sham Balloon Balloon<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Weight change (%of loss or kg): <BR/>First 12 weeks: <BR/>B + S = - 8.6 kg<BR/>S + B = - 5.4 kg<BR/> B + B = - 3.6 kg<BR/>Last 12 weeks: <BR/>B + S = - 10.4 kg<BR/>S + B = - 7.2 kg<BR/>B + B = - 8.6 kg</P>
<P>Weight change (BMI):<BR/>First 12 weeks: <BR/>B + S = - 3.1 kg/m² <BR/>S + B = - 2.3 kg/m² <BR/>B + B = - 2.9 kg/m²</P>
<P>B+S x S+B P = 0.3<BR/>B+S x B+B P = 0.6<BR/>S+B x B+B P = 0.6</P>
<P>Last 12 weeks: <BR/>B + S = - 0.0 kg/m² <BR/>S + B = - 0.7 kg/m² B + B = - 0.4 kg/m²</P>
<P>B+S x S+B P = 0.3<BR/>B+S x B+B P = 0.5<BR/>S+B x B+B P = 0.6</P>
<P>Losses: <BR/>29 exclusions<BR/>1 inability to tolerate crossover endoscopy<BR/>8 lost to follow-up</P>
<P>Complications: <BR/>Small bowel obstruction (2%), Mallory-Weiss tears (11%), Oesophageal laceration (1%)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>In 24 weeks of study: <BR/>There was no significant difference between any of these groups at 12 or 24 wks with respect to weight loss or change in BMI;<BR/>Major part of weight loss during this study occurred during the first 12 weeks period, irrespective of therapy (bubble or sham).<BR/>The use of GEGB did not result in significantly more weight loss than diet and behavioural modification alone.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Geliebter-1990">
<CHAR_METHODS>
<P>Design: <BR/>Single center <BR/>Follow-up: <BR/>3 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: <BR/>U.S.A. <BR/>Number: <BR/>Total 86 <BR/>Sex: <BR/>16 males, 70 females <BR/>Obese individuals with BMI &gt; 40<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>4 groups <BR/>Group 1: Balloon only<BR/>Group 2: Balloon + diet 1000 kcal/day<BR/>Group 3: Diet only<BR/>Group 4: No treatment<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Weight change (%of loss or kg): <BR/>Group 1 (balloon only):<BR/>-3.2 kg (+- 0.9)<BR/>Group 2 (balloon + diet):<BR/>-5.1 kg (+- 1.0)<BR/>Group 3 (diet only):<BR/>-6.9 kg (+- 1.4)<BR/>Group 4 (No treatment): +0.6 kg (+- 0.5)</P>
<P>Losses: 16 <BR/>Group A: 3, <BR/>Group B: 3, <BR/>Group C: 1, <BR/>Group D: 9.<BR/>Side-effects: gastric spasms, nausea, ulcers and superficial erosions.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>First months:<BR/>B produced the larger weight loss. The differences between A, B and C groups were not significant;<BR/>Second month:<BR/>The effect of balloon only (A) diminished relative to the other treatment groups (B and C) so that at the end of the intervention period, it was significantly less effective than the diet only group (C).<BR/>Third month and later:<BR/>All the interventions (A, B, C) produced significantly more weight loss than the control group (D).<BR/>The differences between the balloon only group (A) and the diet only group (C) were no longer significant.<BR/>The body weight of the patients in the treatments groups (A, B, C) remained significantly lower than the control group (D).<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hogan-1989">
<CHAR_METHODS>
<P>Design: <BR/>Single center <BR/>Follow-up: 12 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: <BR/>U.S.A. <BR/>Number: <BR/>Total 59 <BR/>Age (median); <BR/>Balloon 6 male and 28 female <BR/>(33.8 y) <BR/>Sham 5 male and 20 female (36.8 y)</P>
<P>Obese indivuduals above ideal weight<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>3 months with balloon + 9 months of follow-up</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>56 patients completed the first 3 months: 22 sham + 34 balloon</P>
<P>Weight change (%of loss or kg): Balloon = - 7.2%<BR/>Sham= - 8.3%</P>
<P>Weight change (BMI): <BR/>Balloon = - 3.0 kg/m²<BR/>Sham= - 3.5 kg/m²</P>
<P>Normal balloons or over 70% full: <BR/>25 (73%) <BR/>Half empty balloons: <BR/>9 (27%) <BR/>Completely deflated balloons: <BR/>4 (10%)<BR/>Over 50% deflated balloons: <BR/>4 (12%) </P>
<P>Losses:<BR/>1 died (IAM)<BR/>2 moved away <BR/>1 invalid initial weight<BR/>2 realized wasn't using the balloon</P>
<P>Side-effects: <BR/>Dyspepsia, gastric antral ulcers (2 patients), erosions in mucosa (2 patients), erosions in gastric-oesophageal junction (4 patients).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>The loss of weight in the follow-up was difficult to evaluate due to the high rate of drop-outs after removing the balloon; the patients in the final meeting (28 balloon, 16 sham) showed a continuous tendency of weight loss in the control group and of weight gain in the balloon treated group;<BR/>In the 2 weeks after placement of the balloon there was a high incidence of nausea and burning pain in the abdomen when compared to the control group; <BR/>After the end of 3 months there was no significant difference of these symptoms between the 2 groups; <BR/>There was a loss of appetite in the first 3 months in the majority of the patients (for both groups);<BR/>There was no increased early satiation in the patients using the balloon (87%) when compared with the control group (39%). <BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lindor-1987">
<CHAR_METHODS>
<P>Design: <BR/>Single center (Mayo Clinic) <BR/>Follow-up: <BR/>15 months (4 months of observation and pre-selection + 3 months of treatment + 8 months of diet only)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: <BR/>U.S.A. <BR/>Number: <BR/>Total 22 <BR/>Age: <BR/>25-51 years<BR/>Sex: <BR/>20 female and 2 male</P>
<P>21%-77% above ideal body weight:</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>11 underwent insertion of intragastric balloon and 11 underwent sham procedures.<BR/>Results in weight change (% of loss or kg): <BR/>B = -5.8 (+- 5.9 kg) <BR/>Sham = -2.8 (+- 3.9 kg) <BR/>P &gt; 0.15<BR/>95 confidence interval: -1.5 to 7.7 kg<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>8 in 10 balloons were found deflated.</P>
<P>Baloon group: 1 patient showed migration of a deflated balloon through all the intestinal tract; 1 patient had abdominal pain, withdrawing only 3 days after balloon insertion.</P>
<P>Sham group: 2 patients with gastric erosions associated with the use of aspirin.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>There was no important difference in weight loss between these 2 groups.</P>
<P>Costs: The balloon and introducer costs were approximately $400 and the endoscopic charges for insertion and removal of each balloon cost $1200 to $1600 in addition. <BR/>In a 3 months study, these translate into an additional $600 for each kg of weight lost after the balloon procedure.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mathus_x002d_Vliegen-1990">
<CHAR_METHODS>
<P>Design: <BR/>Single center <BR/>Follow-up: <BR/>35 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: <BR/>Netherlands <BR/>Number: <BR/>Total 28 <BR/>Age (median): <BR/>male 33.9 (24-51 y) and female 32.7 (23-53 y) <BR/>Sex: <BR/>15 male, 13 female<BR/>BMI (median): <BR/>male 51.9 kg/m² (43-66) and female 57.1 kg/m² (51-88)<BR/>Weight (mean): <BR/>male 176.5 kg (152.4-220.3) and female 165.6 kg (127.7-191.2)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>4 Groups<BR/>Group A: <BR/>Balloon (for 17 weeks) + sham (17-35 week)<BR/>Group B: <BR/>Sham (for 17 weeks) + balloon (17-35 week)<BR/>Group C: <BR/>Balloon (for 17 weeks) + balloon (17-35 week)<BR/>Group D: <BR/>Sham (for 17 weeks) + sham (17-35 week)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Weight change (%of loss or kg) of all patients: <BR/>Week 0 (mean): <BR/>172 kg<BR/>Week 17:<BR/>134.1 kg (- 37.9 kg) <BR/>Week 0-35:<BR/> - 49.8 kg<BR/>Week 35:<BR/>122.2 kg (- 11.9 kg)</P>
<P>BMI change of all patients:<BR/>Week 0 (mean):<BR/>54.6 kg/m²<BR/>Week 17:<BR/>42.7 kg/m² ( - 11.9)<BR/>Week 35:<BR/>38.8 kg/m² ( - 3.9)</P>
<P>Side-effects in balloon patients: Hiccups and gastric fullness.<BR/>61% were sure to have no balloon.<BR/>After the second period 2 patients had erosions in antrum and 1 had reflux oesophagitis.<BR/>A footnote added to the questionnaires: "&#8230;lying on right side relieve the complaints"<BR/>2 patients with ulcers.</P>
<P>Side-effects in sham-treated patients: nausea, heartburn and belching; 36% were sure that they felt a balloon after the sham<BR/>procedure.1 patient with ulcer.</P>
<P>Losses: <BR/>1 patient had the balloon removed after gastric complaints (Group A); 1 did not attend the visits to the clinic for legitimate reasons (Group A);<BR/>1 showed incooperative behaviour at the time of balloon insertion after 17 weeks - initially compliant work-up (Group B)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mathus_x002d_Vliegen-2005">
<CHAR_METHODS>
<P>Design: <BR/>Single center <BR/>Follow-up: <BR/>2 years(4 periods of 3 months)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: <BR/>Netherlands <BR/>Number: <BR/>Total 43 <BR/>Age (median): <BR/>41.4 (22-64 y)<BR/>Sex: <BR/>23 in group 1 (3 male, 20 female) &amp; 20 in group 2 (4 male, 16 female)<BR/>BMI (median): <BR/>43.3 kg/m² (33,9-61,3) <BR/>Weight (mean): <BR/>125 kg (93.2-187.7)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>3m group 1: Sham<BR/>Group 2: Balloon</P>
<P>3-6m group 1: Balloon<BR/>Group 2: Balloon</P>
<P>After 6months until year one: removal of all balloons and observation of weight maintenance<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>10 excluded patients:<BR/>3 losses, deflated ballon: 1.6% (2/128) and 2.3% (3/128)</P>
<P>Weight change (%of loss or kg):<BR/>0-3 months:<BR/>Sham -11.2 kg (9%)<BR/>Balloon -12.9 kg (10.4%)</P>
<P>3-6 months:<BR/>Balloon -8.8 kg (7.9%) <BR/>patients who had sham therapy in months 0-3<BR/>Balloon -3.9 kg (3.5%) <BR/>patients with second <BR/>balloon treatment period</P>
<P>After 6 months, the overall weight loss was:<BR/>Sham/balloon -20 kg (16.1%)<BR/>Balloon/balloon -16.7 kg (13.4%)</P>
<P>Weight loss in 33 patients who had completed the study per protocol: <BR/>-20.5% (-25.6 kg) after 1 year, and -11.4% (-14.6 kg) after 2 years.</P>
<P>47% of all patients sustained a greater than 10% weight loss, with considerably reduced comorbidity.</P>
<P>Complications: Gastric erosions, gastric ulcers, minor gastric bleeding, Mallory-Weiss tears, oesophageal lacerations<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>55% of patients maintained a weight loss greater than 10%. </P>
<P>Although an independent benefit of balloon treatment beyond diet, exercise, and behavioural therapy could not be demonstrated in the first 3 months, balloon treatment for 1 year resulted in a substantial weigh loss, the greater part of which was maintained during the balloon-free second year.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Meshkinpour-1988">
<CHAR_METHODS>
<P>Design: <BR/>Single center <BR/>Follow-up: <BR/>24 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: <BR/>U.S.A. <BR/>Number: <BR/>Total 23 <BR/>Age (median): <BR/>37.4 y (21-53 y)<BR/>Sex: <BR/>2 male, 21 female<BR/>BMI (median): <BR/>38.3 kg/m² (29.7-50.2) <BR/>Weight (mean): <BR/>25 - 111 % above ideal body weight<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>12 weeks balloon + 12 weeks sham</P>
<P>12 weeks sham + 12 weeks balloon<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Weight change (%of loss or kg): sham +- 0.8 kg (14 patients)<BR/>bubble +-1.7 kg (18 patients)</P>
<P>BMI change: <BR/>sham - 4.9%<BR/>bubble - 5.3%</P>
<P>Losses: <BR/>1 patient passed the bubble *<BR/>1 patient had a deflated device</P>
<P>*1 migration of deflated balloon through abdominal tract</P>
<P>Side-effects: <BR/>Gastric ulcers - 2 patients<BR/>Abdominal cramps - 17 patients<BR/>Nausea<BR/>Vomiting<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Neither mean cumulative weight reduction nor BMI in the 2 evaluation periods (12 wks each) differed significantly;<BR/>the data reveal that with the gastric bubble, weight loss was more significant during the first &amp; second 2 weeks evaluation periods (p&lt;0.005 and p&lt;0.025, respectively). This trend, however, disappeared after the initial 4 weeks of treatment.<BR/>Overweight patients lose weight slowly during both sham procedure and gastric bubble implantation periods;<BR/>the mean cumulative weight loss is not significantly different between the two periods;<BR/>According to the authors, the Garren-Edwards Gastric Bubble tested (GEGB) is of no value as an adjuvant device in weight reduction.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ramhamdany-1989">
<CHAR_METHODS>
<P>Design: <BR/>Single center <BR/>Follow-up: <BR/>6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: <BR/>England <BR/>Number: <BR/>Total 24 <BR/>Sex: <BR/>100% females <BR/>Obese participants with a BMI &gt; 30 Mean BMI: 41 kg/m² <BR/>Mean weight: 110 kg <BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Balloon in 12 patients<BR/>Sham in 12 patients<BR/>Associated with dietary advice (800 kcal/day)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Weight change (%of loss or kg): Balloon -7.33 kg <BR/>Sham -3.33 kg <BR/>(in first 3 months)<BR/> Balloon -9.37 kg <BR/>Sham -4.41 kg <BR/>(in next 6 months) <BR/>p &lt; 0.05</P>
<P>8 losses: 5 put on weight, 2 did not lose weight, did not attend follow- up</P>
<P>Side-effects:<BR/>Abdominal discomfort:<BR/>7 balloon + 0 sham<BR/>Abdominal cramps:<BR/>8 balloon + 0 sham<BR/>Abdominal fullness: 6 balloon + 0 sham<BR/>Vomiting:<BR/>5 balloon + 1 sham<BR/>Nausea:<BR/>10 balloon + 4 sham<BR/>Flatulence:<BR/>6 balloon + 4 sham<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Rigaud-1994">
<CHAR_METHODS>
<P>Design: <BR/>Single center <BR/>Follow-up: <BR/>16 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: <BR/>France <BR/>Number: <BR/>Total 20 <BR/>Age (median): <BR/>Balloon 41.8 (+- 3.1) <BR/>Sham 42.1 (+- 3.3)<BR/>Sex: <BR/>8 males, 12 females <BR/>Obese participants with BMI &gt; 40<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>11 received air-filled balloons,<BR/>9 had a sham procedure.<BR/>All participants had dietary counselling to help them follow a relatively low energy diet (60 % of individual spontaneous intake).<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Weight change (%of loss or kg): Balloon -8.6 kg<BR/>Sham -9.1 kg<BR/>First month:<BR/>P &lt; 0.001<BR/>2nd, 3rd, 4th months:<BR/>P &lt; 0.05</P>
<P>Weight change (BMI): <BR/>Balloon -45,4 (+- 3.3 kg/m²) to -42.2 (+- 3.3 kg/m²) <BR/>Sham -42.8 (+- 3.3 kg/m²) to -39.5 (+- 2.6 kg/m²) <BR/>P &lt; 0.05</P>
<P>Side-Effects "sensation of balloon presence", "gastric distension", "hunger sensation".</P>
<P>There was a considerable correlation between the distension and the presence / sensation of the balloon (r=0.901, p&lt;0.001) and a negative correlation between the hunger and the sensation of distension (r=0.8, p&lt;0.0001)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>The cumulative loss was not significantly different between two groups.<BR/>Most of the weight was lost during the first 4 weeks (P&lt;0.001) in both groups.<BR/>The rate of weight loss decreased significantly, P&lt;0.05 for the 2nd, 3rd and 4th month relative to the 1st month.<BR/>The weight loss between the 2nd and 3rd month was significantly different P&lt;0.05.<BR/>The lowest weight was achieved in both groups 3 months post manipulation.<BR/>The amount of weight lost per month was similar between men and women in both groups, except during the 3rd month when sham balloon men lost significantly (P&lt;0.05) more weight than women.<BR/>The mean energy intake was significantly lower during the first 2 months (P&lt;0.003).<BR/>After 2 months, the balloon group increased progressively the energy intake to initial value, each month being higher from the previous one, and at week 16 there was no difference as compared to week 0.<BR/>The sham balloon group maintained reduced energy intake throughout the 4 months, and at week 16 was 20% lower then at week 0 (P&lt;0.05).<BR/>The monthly energy intake was not significantly different between the two groups.<BR/>Women consumed less energy than men in both groups at all time points (men vs women, months 1 or 2 or 3, balloon group P&lt; 0.05 and sham balloon group P&lt;0.001).<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Al_x002d_Momen-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Baratta-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Barkin-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Benjamin-1988b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Biondi-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Brown-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Busetto-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Butterwegge-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Carim-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Coelho-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Conti-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cormillot-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Darvich-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-De-Luca-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-De-Waele-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-De-Waele-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Doldi-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Doldi-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Durrans-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Evans-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Eynden-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fleisher-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Forestieri-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Galloro-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Galloro-1999b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gau-1989b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Geliebter-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Geliebter-1990b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Genco-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Heraief-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Herzog-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Inappropriate method of randomisation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hodson-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ingelmo-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kim-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kirby-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kobler-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kral-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kramer-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Laurent-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Laurent_x002d_Jaccard-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lieber-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Loffredo-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Luppa-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Marchesini-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Marshall-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mathus_x002d_Vliegen-1990b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mathus_x002d_Vliegen-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mathus_x002d_Vliegen-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mathus_x002d_Vliegen-1997b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mathus_x002d_Vliegen-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mathus_x002d_Vliegen-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Miguel-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Milone-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mion-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mirich-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Neves-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pasquali-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Perez_x002d_Cuadrado-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pizani-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pizani-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pretolesi-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Roman-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Roman-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rubio-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sallet-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sallet-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Scheiderman-1988b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Siardi-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Tosetti-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Totte-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Treacy-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Valad_x00e3_o-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Van-Hee-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention: comparison of the use of anti-emetics after intragastric balloon insertion</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vandenplas-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Velchik-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wahlen-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Weiner-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Weiner-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Inappropriate method of randomisation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Weiner-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Benjamin-1988">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Geliebter-1990">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hogan-1989">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lindor-1987">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mathus_x002d_Vliegen-1990">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Mathus_x002d_Vliegen-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meshkinpour-1988">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Ramhamdany-1989">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rigaud-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-11-10 10:54:09 +0100" MODIFIED_BY="Gudrun Paletta"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-11-10 10:44:40 +0100" MODIFIED_BY="Gudrun Paletta">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Intragastric balloon versus diet</NAME>
<CONT_OUTCOME CHI2="9.561779034563312" CI_END="4.230277598342507" CI_START="2.748831962277757" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.489554780310132" ESTIMABLE="YES" I2="89.54169515541759" I2_Q="0.0" ID="CMP-001.01" NO="1" P_CHI2="0.0019867229151554477" P_Q="1.0" P_Z="2.6213644404296997E-20" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="32" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="9.233415692060543">
<NAME>Weight loss in kg</NAME>
<GROUP_LABEL_1>Intragastric balloon</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Intragastric balloon</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Diet</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.452637188298779" CI_START="2.9473628117012205" EFFECT_SIZE="3.7" ESTIMABLE="YES" MEAN_1="-3.2" MEAN_2="-6.9" ORDER="18763" SD_1="0.9" SD_2="1.4" SE="0.384005621651972" STUDY_ID="STD-Geliebter-1990" TOTAL_1="21" TOTAL_2="18" WEIGHT="96.85902657179302"/>
<CONT_DATA CI_END="1.1794929032459969" CI_START="-7.179492903245997" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-2.8" ORDER="18764" SD_1="5.9" SD_2="3.9" SE="2.132433522357198" STUDY_ID="STD-Lindor-1987" TOTAL_1="11" TOTAL_2="11" WEIGHT="3.1409734282069803"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Intragastric balloon versus no treatment</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="21" TOTAL_2="26" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Weight loss in kg</NAME>
<GROUP_LABEL_1>Intragastric balloon</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Intragastric balloon</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Non treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-3.369758604318897" CI_START="-4.230241395681103" EFFECT_SIZE="-3.8000000000000003" ESTIMABLE="YES" MEAN_1="-3.2" MEAN_2="0.6" ORDER="18765" SD_1="0.9" SD_2="0.5" SE="0.2195149498025435" STUDY_ID="STD-Geliebter-1990" TOTAL_1="21" TOTAL_2="26" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Intragastric balloon versus intragastric balloon + diet</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="21" TOTAL_2="22" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Weight loss in kg</NAME>
<GROUP_LABEL_1>Intragastric balloon</GROUP_LABEL_1>
<GROUP_LABEL_2>Intr. balloon + diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>IGB</GRAPH_LABEL_1>
<GRAPH_LABEL_2>IGB + Diet</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.468139348302415" CI_START="1.3318606516975837" EFFECT_SIZE="1.8999999999999995" ESTIMABLE="YES" MEAN_1="-3.2" MEAN_2="-5.1" ORDER="18766" SD_1="0.9" SD_2="1.0" SE="0.28987234091229547" STUDY_ID="STD-Geliebter-1990" TOTAL_1="21" TOTAL_2="22" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>Intragastric balloon + diet versus diet only</NAME>
<CONT_OUTCOME CHI2="48.39357325935899" CI_END="0.35347550162211533" CI_START="-0.43791043461924356" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.0422174664985641" ESTIMABLE="YES" I2="91.7344396567649" I2_Q="0.0" ID="CMP-004.01" NO="1" P_CHI2="7.813033553460969E-10" P_Q="1.0" P_Z="0.8343596908508971" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="82" TOTAL_2="76" UNITS="" WEIGHT="100.0" Z="0.209113430164562">
<NAME>Weight loss in kg</NAME>
<GROUP_LABEL_1>Intr. balloon + diet</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>IGB + Diet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Diet</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.5753829977546903" CI_START="1.0246170022453112" EFFECT_SIZE="1.8000000000000007" ESTIMABLE="YES" MEAN_1="-5.1" MEAN_2="-6.9" ORDER="18767" SD_1="1.0" SD_2="1.4" SE="0.3956108397250213" STUDY_ID="STD-Geliebter-1990" TOTAL_1="21" TOTAL_2="18" WEIGHT="26.042586623906843"/>
<CONT_DATA CI_END="-0.9988415164354897" CI_START="-2.4011584835645126" EFFECT_SIZE="-1.700000000000001" ESTIMABLE="YES" MEAN_1="-12.9" MEAN_2="-11.2" ORDER="18768" SD_1="1.3" SD_2="1.0" SE="0.35774049375149747" STUDY_ID="STD-Mathus_x002d_Vliegen-1990" TOTAL_1="20" TOTAL_2="23" WEIGHT="31.848155039323093"/>
<CONT_DATA CI_END="0.6901556612128065" CI_START="-1.090155661212807" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" MEAN_1="-5.4" MEAN_2="-5.2" ORDER="18769" SD_1="1.7" SD_2="0.8" SE="0.4541693971084371" STUDY_ID="STD-Meshkinpour-1988" TOTAL_1="18" TOTAL_2="14" WEIGHT="19.759900277931624"/>
<CONT_DATA CI_END="0.10597251895093773" CI_START="-8.105972518950939" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-7.33" MEAN_2="-3.33" ORDER="18770" SD_1="6.12" SD_2="3.9" SE="2.094922432931587" STUDY_ID="STD-Ramhamdany-1989" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.9287195510827462"/>
<CONT_DATA CI_END="1.3549527752025379" CI_START="-0.3549527752025379" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="-8.6" MEAN_2="-9.1" ORDER="18771" SD_1="1.1" SD_2="0.85" SE="0.43620841094341334" STUDY_ID="STD-Rigaud-1994" TOTAL_1="11" TOTAL_2="9" WEIGHT="21.4206385077557"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2008-11-10 10:44:40 +0100" MODIFIED_BY="Gudrun Paletta" NO="5">
<NAME>Minor complications due to balloon usage</NAME>
<DICH_OUTCOME CHI2="1.740884608536545" CI_END="15.350355547338193" CI_START="1.5694089646965579" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="4.908256880733944" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="1.1861184391264794" LOG_CI_START="0.19573612903472984" LOG_EFFECT_SIZE="0.6909272840806048" METHOD="MH" NO="1" P_CHI2="0.883709278115081" P_Q="0.0" P_Z="0.006243970260556787" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="229" TOTAL_2="220" WEIGHT="100.0" Z="2.734686552728525">
<NAME>Gastric ulcers</NAME>
<GROUP_LABEL_1>Intragastric balloon</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Intragastric balloon</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="133.5955115969949" CI_START="0.36677878930404284" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.125791867410467" LOG_CI_START="-0.43559578738195337" LOG_EFFECT_SIZE="0.8450980400142568" ORDER="18772" O_E="0.0" SE="1.5045717874984443" STUDY_ID="STD-Benjamin-1988" TOTAL_1="90" TOTAL_2="90" VAR="2.2637362637362637" WEIGHT="13.990825688073395"/>
<DICH_DATA CI_END="131.56298424105856" CI_START="0.3724451849634156" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1191337160171027" LOG_CI_START="-0.4289376359885893" LOG_EFFECT_SIZE="0.8450980400142568" ORDER="18773" O_E="0.0" SE="1.4967497253247584" STUDY_ID="STD-Geliebter-1990" TOTAL_1="43" TOTAL_2="43" VAR="2.2402597402597397" WEIGHT="13.990825688073395"/>
<DICH_DATA CI_END="163.8618729672792" CI_START="0.5691403770411436" EFFECT_SIZE="9.657142857142857" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.2144779146067735" LOG_CI_START="-0.24478060275201552" LOG_EFFECT_SIZE="0.984848655927379" ORDER="18774" O_E="0.0" SE="1.4445806266225458" STUDY_ID="STD-Hogan-1989" TOTAL_1="34" TOTAL_2="25" VAR="2.086813186813187" WEIGHT="16.05504587155963"/>
<DICH_DATA CI_END="66.52564086017645" CI_START="0.13528618264521788" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8229890669242566" LOG_CI_START="-0.8687465574849316" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="18775" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Lindor-1987" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="13.990825688073395"/>
<DICH_DATA CI_END="15.208600307956246" CI_START="0.06575227040958258" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1820892464985915" LOG_CI_START="-1.1820892464985915" LOG_EFFECT_SIZE="0.0" ORDER="18776" O_E="0.0" SE="1.3887301496588271" STUDY_ID="STD-Mathus_x002d_Vliegen-1990" TOTAL_1="28" TOTAL_2="28" VAR="1.9285714285714284" WEIGHT="27.98165137614679"/>
<DICH_DATA CI_END="98.75289399148167" CI_START="0.25315713787746275" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9945498316515593" LOG_CI_START="-0.596609822979522" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="18777" O_E="0.0" SE="1.52206000757745" STUDY_ID="STD-Meshkinpour-1988" TOTAL_1="23" TOTAL_2="23" VAR="2.316666666666667" WEIGHT="13.990825688073395"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.2705774602655038" CI_END="24.69394187156617" CI_START="3.870198300588245" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="9.776014109347443" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="1.3925904215003861" LOG_CI_START="0.5877332178987233" LOG_EFFECT_SIZE="0.9901618196995547" METHOD="MH" NO="2" P_CHI2="0.6583492431384136" P_Q="0.0" P_Z="1.4182379467954228E-6" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="249" TOTAL_2="240" WEIGHT="100.00000000000001" Z="4.82242439228573">
<NAME>Gastric erosions</NAME>
<GROUP_LABEL_1>Intragastric balloon</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Intragastric balloon</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="762.175140006157" CI_START="2.898283982316917" EFFECT_SIZE="47.0" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="0" LOG_CI_END="2.8820547792115083" LOG_CI_START="0.4621409366599265" LOG_EFFECT_SIZE="1.6720978579357175" ORDER="18778" O_E="0.0" SE="1.4214693698815108" STUDY_ID="STD-Benjamin-1988" TOTAL_1="90" TOTAL_2="90" VAR="2.0205751695113396" WEIGHT="10.405643738977073"/>
<DICH_DATA CI_END="101.18091723147054" CI_START="0.24708216414768958" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0050986120834273" LOG_CI_START="-0.6071586034113897" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="18779" O_E="0.0" SE="1.5344528192634188" STUDY_ID="STD-Geliebter-1990" TOTAL_1="43" TOTAL_2="43" VAR="2.354545454545454" WEIGHT="10.405643738977073"/>
<DICH_DATA CI_END="15.327063782400595" CI_START="0.8818672759540225" EFFECT_SIZE="3.676470588235294" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.1854589646888694" LOG_CI_START="-0.05459677275726693" LOG_EFFECT_SIZE="0.5654310959658013" ORDER="18780" O_E="0.0" SE="0.7284148785507594" STUDY_ID="STD-Hogan-1989" TOTAL_1="34" TOTAL_2="25" VAR="0.5305882352941176" WEIGHT="47.97178130511464"/>
<DICH_DATA CI_END="149.49543567858223" CI_START="0.5418225622229123" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.1746279331964633" LOG_CI_START="-0.2661429143178138" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="18781" O_E="0.0" SE="1.4337208778404378" STUDY_ID="STD-Lindor-1987" TOTAL_1="11" TOTAL_2="11" VAR="2.0555555555555554" WEIGHT="10.405643738977073"/>
<DICH_DATA CI_END="129.5480077181774" CI_START="0.37823815945202377" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1124307384823604" LOG_CI_START="-0.42223465845384694" LOG_EFFECT_SIZE="0.8450980400142568" ORDER="18782" O_E="0.0" SE="1.4888750009563954" STUDY_ID="STD-Mathus_x002d_Vliegen-1990" TOTAL_1="28" TOTAL_2="28" VAR="2.2167487684729066" WEIGHT="10.405643738977073"/>
<DICH_DATA CI_END="162.21628593010868" CI_START="0.499333340888467" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2100944536637974" LOG_CI_START="-0.3016094347851477" LOG_EFFECT_SIZE="0.9542425094393249" ORDER="18783" O_E="0.0" SE="1.4753872972096773" STUDY_ID="STD-Mathus_x002d_Vliegen-2005" TOTAL_1="43" TOTAL_2="43" VAR="2.1767676767676765" WEIGHT="10.405643738977073"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.2742167336039785" CI_END="56.744911692801864" CI_START="3.454054190110982" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="14.0" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="1.7539269244940117" LOG_CI_START="0.5383291468624642" LOG_EFFECT_SIZE="1.146128035678238" METHOD="MH" NO="3" P_CHI2="0.5174783986568181" P_Q="0.0" P_Z="2.1910103772059005E-4" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="136" TOTAL_2="136" WEIGHT="100.0" Z="3.6959094742304943">
<NAME>Abdominal pain</NAME>
<GROUP_LABEL_1>Intragastric balloon</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Intragastric balloon</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="72.67543752715288" CI_START="0.12383826374127341" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.861387655028722" LOG_CI_START="-0.9071451455893973" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="18784" O_E="0.0" SE="1.626249871541469" STUDY_ID="STD-Benjamin-1988" TOTAL_1="90" TOTAL_2="90" VAR="2.6446886446886446" WEIGHT="25.0"/>
<DICH_DATA CI_END="66.52564086017645" CI_START="0.13528618264521788" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8229890669242566" LOG_CI_START="-0.8687465574849316" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="18785" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Lindor-1987" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="25.0"/>
<DICH_DATA CI_END="549.4661452625453" CI_START="2.2294367188258173" EFFECT_SIZE="35.0" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="0" LOG_CI_END="2.7399409390186436" LOG_CI_START="0.3481951496819071" LOG_EFFECT_SIZE="1.5440680443502757" ORDER="18786" O_E="0.0" SE="1.4049233159889987" STUDY_ID="STD-Meshkinpour-1988" TOTAL_1="23" TOTAL_2="23" VAR="1.9738095238095237" WEIGHT="25.0"/>
<DICH_DATA CI_END="236.41927466233471" CI_START="0.9516990538159615" EFFECT_SIZE="15.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.3736828805774706" LOG_CI_START="-0.02150036246610839" LOG_EFFECT_SIZE="1.1760912590556813" ORDER="18787" O_E="0.0" SE="1.4069424933120682" STUDY_ID="STD-Ramhamdany-1989" TOTAL_1="12" TOTAL_2="12" VAR="1.9794871794871793" WEIGHT="25.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.07096628303605335" CI_END="23.212304265401997" CI_START="0.808957937268042" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="4.333333333333333" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-005.04" LOG_CI_END="1.365718254634138" LOG_CI_START="-0.09207405945978955" LOG_EFFECT_SIZE="0.6368220975871743" METHOD="MH" MODIFIED="2008-11-10 10:44:40 +0100" MODIFIED_BY="Gudrun Paletta" NO="4" P_CHI2="0.7899350398866899" P_Q="0.0" P_Z="0.08682636560717222" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="98" TOTAL_2="98" WEIGHT="100.0" Z="1.712381611239162">
<NAME>Vomiting</NAME>
<GROUP_LABEL_1>Intragastric balloon</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Intragastric balloon</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="72.63119325289044" CI_START="0.1239137014954911" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8611231792142506" LOG_CI_START="-0.9068806697749261" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="18788" O_E="0.0" SE="1.6259391627362754" STUDY_ID="STD-Geliebter-1990" TOTAL_1="86" TOTAL_2="86" VAR="2.64367816091954" WEIGHT="33.333333333333336"/>
<DICH_DATA CI_END="36.664177584046264" CI_START="0.6818644695545626" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.5642419477602025" LOG_CI_START="-0.1663019390881651" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="18789" O_E="0.0" SE="1.0165300454651272" STUDY_ID="STD-Ramhamdany-1989" TOTAL_1="12" TOTAL_2="12" VAR="1.0333333333333334" WEIGHT="66.66666666666667"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>Major complications due to balloon usage</NAME>
<DICH_OUTCOME CHI2="0.011071433273683366" CI_END="24.012955227009158" CI_START="0.2961364415119016" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.6666666666666665" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="1.380445611110941" LOG_CI_START="-0.5285081465663789" LOG_EFFECT_SIZE="0.4259687322722811" METHOD="MH" NO="1" P_CHI2="0.9162005451103666" P_Q="0.0" P_Z="0.3817357735931197" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="29" TOTAL_2="25" WEIGHT="100.0" Z="0.8747025646233387">
<NAME>Migration of deflated balloon</NAME>
<GROUP_LABEL_1>Intragastric balloon</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Intragastric balloon</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="66.52564086017645" CI_START="0.13528618264521788" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8229890669242566" LOG_CI_START="-0.8687465574849316" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="18790" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Lindor-1987" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="47.22222222222222"/>
<DICH_DATA CI_END="54.077576564542056" CI_START="0.10372909880407802" EFFECT_SIZE="2.3684210526315788" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7330172208731258" LOG_CI_START="-0.9840993952280964" LOG_EFFECT_SIZE="0.3744589128225147" ORDER="18791" O_E="0.0" SE="1.5960477502420256" STUDY_ID="STD-Meshkinpour-1988" TOTAL_1="18" TOTAL_2="14" VAR="2.547368421052631" WEIGHT="52.77777777777778"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="90" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>Small bowel obstruction</NAME>
<GROUP_LABEL_1>Intragastric balloon</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Intragastric balloon</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="133.5955115969949" CI_START="0.36677878930404284" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.125791867410467" LOG_CI_START="-0.43559578738195337" LOG_EFFECT_SIZE="0.8450980400142568" ORDER="18792" O_E="0.0" SE="1.5045717874984443" STUDY_ID="STD-Benjamin-1988" TOTAL_1="90" TOTAL_2="90" VAR="2.2637362637362637" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="90" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>Mallory-Weiss tears</NAME>
<GROUP_LABEL_1>Intragastric balloon</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Intragastric balloon</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="353.06042968771106" CI_START="1.2490779563999093" EFFECT_SIZE="21.0" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="0" LOG_CI_END="2.547849045426937" LOG_CI_START="0.09658954404090134" LOG_EFFECT_SIZE="1.3222192947339193" ORDER="18793" O_E="0.0" SE="1.4398819650443828" STUDY_ID="STD-Benjamin-1988" TOTAL_1="90" TOTAL_2="90" VAR="2.0732600732600734" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="90" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>Oesophageal laceration</NAME>
<GROUP_LABEL_1>Intragastric balloon</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Intragastric balloon</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="72.67543752715288" CI_START="0.12383826374127341" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.861387655028722" LOG_CI_START="-0.9071451455893973" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="18794" O_E="0.0" SE="1.626249871541469" STUDY_ID="STD-Benjamin-1988" TOTAL_1="90" TOTAL_2="90" VAR="2.6446886446886446" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-11-10 11:13:07 +0100" MODIFIED_BY="Gudrun Paletta">
<APPENDIX ID="APP-01" MODIFIED="2008-10-23 10:56:13 +0200" MODIFIED_BY="Gudrun Paletta" NO="1">
<TITLE MODIFIED="2008-10-23 10:56:00 +0200" MODIFIED_BY="Gudrun Paletta">Search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-10-23 10:56:13 +0200" MODIFIED_BY="Gudrun Paletta">
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>Search items</P>
</TH>
</TR>
<TR>
<TD>
<P>ELECTRONIC SEARCHES:<BR/>Unless otherwise stated, search terms were free text terms; exp = exploded MeSH: Medical subject heading (Medline medical index term); the asterisk (*) stands for any character(s).<BR/>
<BR/>1. "gastric balloon"[All Fields]<BR/>2. "gastric balloons"[All Fields])<BR/>3. "gastric bubble"[All Fields]<BR/>4. "gastric bubbles"[All Fields])<BR/>5. "intragastric balloon"[All Fields]<BR/>6. "intragastric balloons"[All Fields])<BR/>7. "intragastric bubble"[All Fields]<BR/>8. "stomach bubble"[All Fields]<BR/>
<BR/>9. or/#1-#8<BR/>
<BR/>10. "obes*"[All Fields]<BR/>11. "weight gain*"[All Fields]<BR/>12. "weight loss"[All Fields]<BR/>13. "body mass ind*"[All Fields]<BR/>14. "adipos*"[All Fields]<BR/>15. "overweight"[All Fields]<BR/>16. "over weight"[All Fields]<BR/>17. "overload syndrom"[All Fields]<BR/>18. "overeat*"[All Fields]<BR/>19. "over eat*"[All Fields]<BR/>20. "overfeed*"[All Fields]<BR/>21. "over feed*"[All Fields]<BR/>22. "weight cycling"[All Fields]<BR/>23. "weight reduc*"[All Fields]<BR/>24. "weight losing""[All Fields]<BR/>25. "weight maint*"[All Fields]<BR/>26. "weight decreas*"[All Fields]<BR/>27. "weight watch*"[All Fields]<BR/>28. "weight control*"[All Fields]<BR/>
<BR/>29. or/#10-#28<BR/>
<BR/>30. randomized-controlled-trial[Publication Type]<BR/>31. randomized-controlled-trials[MeSH Terms]<BR/>32. random allocation[MeSH Terms]<BR/>33. random*[Title/Abstract]<BR/>34. alloc*[Title/Abstract]<BR/>35. assign*[Title/Abstract]<BR/>36. controlled-clinical-trial[Publication Type]<BR/>37. clinical-trial[Publication Type]<BR/>38. clinical trials[MeSH Terms]<BR/>39. clinical trial*[Title/Abstract]<BR/>40. cross-over-studies[MeSH Terms]<BR/>41. cross-over stud*[Title/Abstract]<BR/>42. crossover stud*[Title/Abstract]<BR/>43. cross-over trial*[Title/Abstract]<BR/>44. crossover trial*[Title/Abstract]<BR/>45. cross-over design*[Title/Abstract<BR/>46. crossover design*[Title/Abstract]<BR/>47. double-blind-method[MeSH Terms]<BR/>48. single-blind-method[MeSH Terms]<BR/>49. singl* blind*[Title/Abstract]<BR/>50. singl* mask*[Title/Abstract]<BR/>51. doubl* blind*[Title/Abstract]<BR/>52. double* mask*[Title/Abstract]<BR/>53. trebl* blind*[Title/Abstract]<BR/>54. trebl* mask*[Title/Abstract]<BR/>55. tripl* blind*[Title/Abstract]<BR/>56. tripl* mask*[Title/Abstract]<BR/>57. Placebo[MeSH Terms]<BR/>58. placebo*[Title/Abstract]<BR/>59. research design[MeSH Terms]<BR/>60. comparative study[MeSH Terms]<BR/>61. evaluation studies[MeSH Terms]<BR/>62. follow-up studies[MeSH Terms]<BR/>63. prospective studies[MeSH Terms]<BR/>64. control*[Title/Abstract]<BR/>65. prospectiv*[Title/Abstract]<BR/>66. volunteer*[Title/Abstract]<BR/>
<BR/>67. or/#30-#66<BR/>
<BR/>68. #9 and #29 and #67<BR/>
</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2008-11-10 10:47:23 +0100" MODIFIED_BY="Gudrun Paletta" NO="2">
<TITLE MODIFIED="2008-11-10 10:45:25 +0100" MODIFIED_BY="Gudrun Paletta">Risk of bias</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-10 10:47:23 +0100" MODIFIED_BY="Gudrun Paletta">
<TABLE COLS="8" ROWS="11">
<TR>
<TH>
<P>Publication</P>
</TH>
<TH>
<P>Randomisation</P>
</TH>
<TH>
<P>Concealment</P>
</TH>
<TH>
<P>Attrition described</P>
</TH>
<TH>
<P>ITT analysis</P>
</TH>
<TH>
<P>Assessors blinded</P>
</TH>
<TH>
<P>Cochrane categories</P>
</TH>
<TH>
<P>Jadad scale</P>
</TH>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Was the randomisation procedure adequate?</P>
</TD>
<TD>
<P>Was the allocation of concealment<BR/>adequate?<BR/>
</P>
</TD>
<TD>
<P>Were withdrawls and dropouts completely described?</P>
</TD>
<TD>
<P>Was analysis by intention-to-treat?</P>
</TD>
<TD>
<P>Were outcome assessors blind to the intervention?</P>
</TD>
<TD>
<P>Category A, B or C?</P>
</TD>
<TD>
<P>Scale<BR/>1,2,3,4 or 5?<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Lindor KD<BR/>1987<BR/>
<BR/>
</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Benjamin S<BR/>1988<BR/>
</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>5</P>
</TD>
</TR>
<TR>
<TD>
<P>Meshkinpour H<BR/>1988<BR/>
</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Hogan RB<BR/>1989<BR/>
</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>5</P>
</TD>
</TR>
<TR>
<TD>
<P>Ramhamdany E<BR/>1989<BR/>
</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>5</P>
</TD>
</TR>
<TR>
<TD>
<P>Geliebter A<BR/>1990<BR/>
</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus-Vliegen E<BR/>1990<BR/>
</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Rigaud D<BR/>1994<BR/>
</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>5</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus-Vliegen E<BR/>2005<BR/>
</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>5</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2008-11-10 11:13:07 +0100" MODIFIED_BY="Gudrun Paletta" NO="3">
<TITLE MODIFIED="2008-11-10 11:13:07 +0100" MODIFIED_BY="Gudrun Paletta">Outcome data</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-10 10:48:16 +0100" MODIFIED_BY="Gudrun Paletta">
<TABLE COLS="10" ROWS="14">
<TR>
<TH>
<P>Publication</P>
</TH>
<TH>
<P>Weight change (kg,%)</P>
</TH>
<TH>
<P>Weight change (BMI)</P>
</TH>
<TH>
<P>Technical failure</P>
</TH>
<TH>
<P>Revision rates</P>
</TH>
<TH>
<P>Major complications</P>
</TH>
<TH>
<P>Minor complications</P>
</TH>
<TH>
<P>Comorbidity</P>
</TH>
<TH>
<P>Costs</P>
</TH>
<TH>
<P>Events / Procedures</P>
</TH>
</TR>
<TR>
<TD>
<P>Benjamin 1988<BR/>
</P>
</TD>
<TD>
<P>FIRST 12 WEEKS<BR/>BS: -8,6 Kg<BR/>SB: -5,4 Kg<BR/>BB: -3,6 Kg<BR/>LAST 12 WEEKS<BR/>BS: -10,4 Kg<BR/>SB: -7,2 Kg<BR/>BB: -8,16 Kg</P>
</TD>
<TD>
<P>FIRST 12 WEEKS<BR/>BS: -3.1 Kg/m²<BR/>SB: -2.3 Kg/m²<BR/>BB: -2.9 Kg/m²<BR/>(no statistics<BR/>differences between these groups)<BR/>(BS x SB p=0.3)<BR/>(BS x BB p=0.6)<BR/>(SB x BB p=0.6)<BR/>
<BR/>LAST 12 WEEKS<BR/>BS: 0.0 Kg/m²<BR/>SB: -0.7 Kg/m²<BR/>BB: -0.4 Kg/m²<BR/>(no statistics<BR/>differences between these groups)<BR/>(BS x SB p=0.3)<BR/>(BS x BB p=0.5)<BR/>(SB x BB p=0.6)<BR/>
</P>
</TD>
<TD>
<P>1 Inability to tolerate crossover endoscopy</P>
</TD>
<TD>
<P>29 losses (excluded)<BR/>8 Lost follow-up<BR/>
<BR/>
</P>
</TD>
<TD>
<P>Small bowel obstruction (2%)<BR/>Mallory-Weiss tears (11%)<BR/>Oesophageal laceration (1%)</P>
</TD>
<TD>
<P>23 Gastric erosions (26%)<BR/>20 varioliform erosions<BR/>03 hyperplasia of gastric epithelium covered by acute inflammatory infiltrate<BR/>3 Gastric ulcers + pain (14%)<BR/>11 requested withdrawal without reason<BR/>2 became pregnant during study<BR/>1 Abdominal pain, no ulcer found<BR/>3 Small bowel obstructions (2 %)<BR/>8 Lost to follow-up<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Randomisation was done by sealed envelope. Patients were randomly assigned to one of three groups: sham-bubble (SB); bubble-sham (BS) or bubble-bubble (BB). After 12 wk of concurrent diet and behavioural modification therapy in the EDC and biweekly follow-up by a nurse practitioner in the Gastroenterology Clinic to assess any symptoms possibly related to the GEGB, patients again underwent endoscopy. The GEGB was removal (if present) and replaced for SB and BB patients.</P>
</TD>
</TR>
<TR>
<TD>
<P>Geliebter 1990</P>
</TD>
<TD>
<P>Group 1 (Only balloon): -3,2 kg +/- 0,9<BR/>Group 2 (balloon + diet): -5,1 kg +/- 1,0<BR/>Group 3 (only diet): -6,9 kg +/- 1,4<BR/>Group 4 (no treatment): +0,6 kg +/- 0,5<BR/>
<BR/>(3 months)<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>16 losses<BR/>Group A: 3<BR/>Group B: 3<BR/>Group C: 1<BR/>Group D: 9<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Gastric spasms<BR/>Nausea<BR/>Ulcers<BR/>Superficial erosions<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>The subjects were randomly assigned to the following groups: (1) gastric balloon only; (2) gastric balloon and prescribed 1000 kcal/day diet, and (3) 1000 kacl/day diet only. Patients who declined to participate in the study at the initial interview were asked to be in another group of (4) no treatment. They were weighed at the onset and after 3 months.</P>
</TD>
</TR>
<TR>
<TD>
<P>Hogan 1989<BR/>
</P>
</TD>
<TD>
<P>B: -7.2%<BR/>S: -8.3%<BR/>
</P>
</TD>
<TD>
<P>B: -3.0 kg/m²<BR/>S: -3.5 kg/m²<BR/>
</P>
</TD>
<TD>
<P>Normal balloons or over 70% full: 25 (73%)<BR/>Half empty balloons: 9 (27%)<BR/>Completely deflated balloons: 4 (10%)<BR/>Over 50% deflated balloons: 4 (12%)<BR/>9 of the 59 patients did not go to 80% of the meetings<BR/>
</P>
</TD>
<TD>
<P>6 losses<BR/>1died (IAM)<BR/>2 moved away withdrawing the program<BR/>1 invalid initial weight<BR/>2 realized wasn't using the balloon<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Dyspepsia<BR/>Gastric antral ulcers: 2 p<BR/>Erosions in mucosa: 2 p<BR/>Erosions in gastric-oesophageal junction: 4 p<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>After acceptance into study, all patients were entered into SWLP plus either sham or bubble placement. Three months of treatment were concluded by either bubble removal or sham removal. Following removal all patients were followed for a 9 month period of continued weight loss therapy and observed for weight loss or gain. Weight loss was recorded weekly during the period of bubble/sham placement, then biweekly over the next 3 months. Over the 6 months, monthly meetings took place.</P>
</TD>
</TR>
<TR>
<TD>
<P>Lindor 1987<BR/>
</P>
</TD>
<TD>
<P>B: -5.8 +/- 5.9 kg<BR/>S: -2.8 +/- 3.9 kg p&gt;0.15<BR/>
<BR/>Confidence Interval: 95% of weight loss during use of balloon was between -1.5 to 7.7 kg<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>8 in 10 balloons were found desinsuflated<BR/>The desinsuflation tax and damage to the gastric mucosa was unacceptably high.<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>BALLOON group:<BR/>Migration of a desinsuflated balloon through all intestinal tract - 1 patient.<BR/>
</P>
</TD>
<TD>
<P>SHAM group:<BR/>Gastric erosions associated with the use of aspirin - 2 patients;<BR/>
<BR/>BALLOON group:<BR/>Abdominal pain and withdrawing in 3 days after balloon insertion - 1 patient.<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>The balloon and introducer cost approximately $400, and the endoscopic charges for insertion and removal of each balloon are $1,200 to $ 1,600 in addition. In 3 months study, this translated into an additional $600 for each kilogram of weight lost with the balloon.</P>
</TD>
<TD>
<P>The study was initially designed to allow 2 months of observation after randomisation, followed by a second 4 month period of crossover treatment, and finally an additional 8 months of observation during which no patients would have intragastric balloons. All patients received instructions for diets designed to result in a daily 400 to 800 calorie deficit, as assessed by indirect calorimetry and reported activity.</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus-Vliegen 1990</P>
</TD>
<TD>
<P>Weight lost (mean all patients):<BR/>Week 0: -19.8 kg<BR/>Week 17: -17.5 kg<BR/>Week 35: -20.5 kg</P>
</TD>
<TD>
<P>All patients(mean):<BR/>Week 0: -5.9 kg/m²<BR/>Week 17: -6.4 kg/m² (-11,9)<BR/>Week 35: -7.2 kg/m² (-3,9)<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>3 losses:<BR/>01 Balloon removed after gastric complaints<BR/>01 not attend the visits to the clinic for legitimate reasons<BR/>01 incooperative behaviour at the time of balloon insertion after initially compliant workup<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Balloon patient: Hiccups; Gastric fullness<BR/>2 patients with ulcers<BR/>After the second period 2 patients had raised erosions in antrum<BR/>1 had reflux oesophagitis<BR/>
<BR/>Footnote added to questionnaires:<BR/>"&#8230;lying on right side relieve the complaints"<BR/>
<BR/>61% are sure have NO BALLOON<BR/>
<BR/>Sham-treated patients:<BR/>Nausea<BR/>Heartburn<BR/>Belching<BR/>1 patient with ulcer<BR/>
<BR/>36% are sure that felt a balloon after sham<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Patients were matched for sex and weight and were stratified into four treatment groups: group A, balloon-sham; group B, sham-balloon; group C, balloon-balloon; and group D, sham-sham. The treatment included two periods each of balloon or sham therapy for 4 months (17.5 wk). Endoscopy was performed three times: first to secure the absence of any lesion precluding balloon insertion and to measure the distance from the incisor teeth to the diaphragm; second (after 4 months) to remove the balloon, if present, to reinvestigate the absence of lesions, and to measure the distance between the oral cavity and diaphragm; and third (after another 4 months) for removal of the balloon and final inspection of the gastrointestinal mucosa.</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus-Vliegen 2005</P>
</TD>
<TD>
<P>0-3m:<BR/>S: -11,2 kg (9.0%)<BR/>B: -12,9 kg (10,4%)<BR/>
<BR/>3-6m:<BR/>B: -8,8 kg (7.9%)<BR/>(patients who had sham therapy in months 0-3)<BR/>
<BR/>B: -3,9 kg (3,5%)<BR/>(their second balloon treatment period)<BR/>
<BR/>After 6m:<BR/>The overall weight loss was:<BR/>Sham/balloon: -20 kg (16,1%)<BR/>Balloon/balloon: -16,7 kg (13.4%)<BR/>(not significant)<BR/>
<BR/>In 33 patients who had completed the study per protocol<BR/>weight loss was:<BR/>-20.5%<BR/>(-25.6 kg) after 1 y<BR/>-11.4%<BR/>(-14.6 kg) after 2y<BR/>55% maintained a weight loss of greater than 10%.</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>3 losses<BR/>Desinsuflation tax 1.6% (2/128)<BR/>2.3% (3/128)<BR/>
</P>
</TD>
<TD>
<P>10 excluded</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Gastric erosions<BR/>Gastric ulcers<BR/>Minor gastric bleeding<BR/>Mallory-Weiss tears<BR/>Esophageal lacerations<BR/>
</P>
</TD>
<TD>
<P>47% of all patients sustained a greater than 10% weight loss, with considerably reduced comorbidity.</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Adults with treatment-resistant obesity and no GI contraindications to balloon placement were invited to participate in a randomised, double-blind trial of balloon or sham treatment of 3 months' duration. Patients (sham-and balloon-treated groups) in whom a preset weight-loss goal was achieved were given an additional 9 months of balloon treatment. After removal of the balloon at year 1, patients were followed for a second year without the balloon.</P>
</TD>
</TR>
<TR>
<TD>
<P>Meshkinpour 1988<BR/>
</P>
</TD>
<TD>
<P>S: -5,2 +/- 0.8 kg (14 patients)<BR/>B: -5,4 +/- 1.7 kg (18 patients)<BR/>
</P>
</TD>
<TD>
<P>S: - 4.9%<BR/>B: - 5.3%<BR/>
</P>
</TD>
<TD>
<P>1passed the bubble<BR/>1deflated device<BR/>
</P>
</TD>
<TD>
<P>2 losses<BR/>1 passed the bubble<BR/>1deflated device</P>
</TD>
<TD>
<P>Migration of deflated balloon through abdominal tract - 1 patient<BR/>
</P>
</TD>
<TD>
<P>Gastric Ulcers - 2 patients<BR/>Abdomen cramps - 17 patients<BR/>Nausea<BR/>Vomiting<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Patients were studied for 2 wk, consisting of two separate 12 wk evaluation periods. They were randomly assigned to either receive the Garren-Edwards gastric bubble or have a sham procedure. After the first 12 wk evaluation period, the gastric bubble and sham were administered in crossover fashion, so that those who had received the gastric bubble initially received the sham later and vice-versa.<BR/>The study coordinator remained blind to the kind of treatment, weighed each patient biweekly, enforced the dietary counselling, provided behaviour modification, and recorded the patient's subjective awareness on the type of treatment. The program was administered at biweekly intervals to a group of 5-7 individuals at each session and continued for the entire treatment period.<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Ramhamdany 1989</P>
</TD>
<TD>
<P>B: -7.33 kg<BR/>S: -3.33 kg<BR/>(3 months)<BR/>
<BR/>B: -9.37 kg<BR/>S: -4.41 kg<BR/>(6 months)<BR/>
<BR/>p &lt; 0.05<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>8 losses<BR/>5 put on weight<BR/>2 did not lose weight<BR/>1 did not attend follow up<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>12<BR/>Abdominal discomfort: 7 Balloon + 0 sham<BR/>Abdominal cramps: 8 Balloon + 0 sham<BR/>Abdominal fullness: 6 Balloon + 0 sham<BR/>Vomiting: 5 Balloon +1 sham<BR/>Nausea: 10 balloon + 4 sham<BR/>Flatulence: 6 balloon + 4 sham</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Patients were randomised to balloon or non-balloon management according to numbers which had been previously randomly allocated, by independent observer, at the start of the trial and kept in a sealed envelope until the end of the study. Patients and dietitian were unaware of any individual's assigned treatment. Gastroscopy was performed in all patients before the procedure to exclude oesophageal or gastric lesions. All patients received similar dietary advice of 800 kcal daily from the dietitian knew who supervised the dietary habits of every patient. Neither the patient nor the dietitian knew who had the balloon.<BR/>Patients were seen every two weeks for the first three months, advised about their diets and weighed. Side effects were recorded. After three months, gastroscopy was performed to see if the balloon was still inflated and to exclude the development of gastritis or gastric ulceration. Patients were followed up for a further three months after balloon removal.</P>
</TD>
</TR>
<TR>
<TD>
<P>Rigaud 1994</P>
</TD>
<TD>
<P>Cumulative loss<BR/>B: -8.6 kg<BR/>S: -9.1 kg<BR/>In both groups in the 1st Month: p &lt; 0.001<BR/>2nd,3rd,4th months p &lt; 0.05<BR/>Balloon<BR/>1ºM -5,0 +/- 0,8 kg<BR/>2ºM -1,5 +/- 1,1 kg<BR/>3ºM -0,9 +/- 1,1 kg<BR/>4ºM +0,7 +/- 1,4 kg<BR/>Sham<BR/>1ºM -5,1 +/- 1,1 kg<BR/>2ºM -3,3 +/- 0,7 kg<BR/>3ºM -1,0 +/- 0,7 kg<BR/>4ºM -0,3 +/- 0,9 kg</P>
</TD>
<TD>
<P>B: 45,4+/- 3.3 kg/m² to 42,2 +/- 3,3 kg/m²<BR/>S: 42.8+/- 3.3 kg/m² to 39,5+/- 2.6 kg/m²<BR/>P&lt;0.05<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>"Sensation of balloon presence<BR/>"Gastric distension<BR/>"Hunger sensation<BR/>There is a strong correlation between the distension and the presence sensation of the balloon (r=0.901 p&lt;0.001) and a negative correlation between the hunger and the sensation of distension (r=0.8 p&lt;0.0001)<BR/>
</P>
</TD>
<TD>
<P>Respiratory Insufficiency<BR/>HAS<BR/>DM<BR/>
<BR/>³Initially the glycemic curve suggests hyperglycemias and insulin resistance; ³It was discrete in the values of glucose in 120´ in the 4th month, when compared to the basic tx (7.3 +- 0.8 mmol/l and 9.7 +- 1.2 mmol/l)<BR/>³Initial/ the value was lower in the group of the balloon in relation to the control (60, 90 and 120 min, p&lt;0.05)<BR/>³The final value was only significant/ different (p&lt;0.05) in 60 minutes, between the balloon and the control (8.9 +- 0.78 Vs 10.16 +- 0.54)<BR/>³In the 120-minute there was no return to the initial values in neither groups.<BR/>
<BR/>Triglycerides, cholesterol total, HDL, and LDL don´t suffer modification during test period<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>During biweekly visits, bodyweight was recorded, visual analogic scales for stomach distension, hunger and feeling of balloon presence were completed. Blood chemistry profiles were monitored once every 4 weeks.</P>
</TD>
</TR>
<TR>
<TD>
<P>Abbreviations used:<BR/>Sham (S) = sham operation<BR/>Bubble (B) = intragastric balloon</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2008-11-10 10:48:28 +0100" MODIFIED_BY="Gudrun Paletta" NO="4">
<TITLE MODIFIED="2008-11-10 10:45:48 +0100" MODIFIED_BY="Gudrun Paletta">Weight change (loss in % or kg)</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-10 10:48:28 +0100" MODIFIED_BY="Gudrun Paletta">
<TABLE COLS="2" ROWS="12">
<TR>
<TH>
<P>Publication</P>
</TH>
<TH>
<P>Weight change</P>
</TH>
</TR>
<TR>
<TD>
<P>Lindor<BR/>1987</P>
</TD>
<TD>
<P>B = -5.8 + / - 5.9 kg<BR/>S = -2.8 + / - 3.9 kg<BR/>(p&gt;0.15)<BR/>95% confidence interval of weight loss during balloon usage was -1.5 to 7.7 kg<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Benjamin<BR/>1988</P>
</TD>
<TD>
<P>First 12 weeks:<BR/>BS = -8.6 kg<BR/>SB = -5.4 k<BR/>BB = -3.6 k<BR/>
<BR/>Last 12 weeks:<BR/>BS = -10.4 kg<BR/>SB = -7.2 kg<BR/>BB = -8.16 kg<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Meshkinpour<BR/>1988</P>
</TD>
<TD>
<P>Lost weight:<BR/>Sham - 5.2 +/- 0.8 kg (14 patients)<BR/>Bubble - 5.4 +/- 1.7 kg (18 patients)<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Hogan<BR/>1989</P>
</TD>
<TD>
<P>Balloon = -7.2 %<BR/>Sham = -8.3 %<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Ramhamdany<BR/>1989</P>
</TD>
<TD>
<P>B -7.33 kg<BR/>S -3.33 kg<BR/>(3 months)<BR/>
<BR/>B 9.37 kg<BR/>S 4.41 kg<BR/>(6 months)<BR/>
<BR/>p &lt; 0.05<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Geliebter<BR/>1990</P>
</TD>
<TD>
<P>Group 1 (balloon only): -3.2 kg +/- 0.9<BR/>Group 2 (balloon + diet): -5.1 kg +/- 1.0<BR/>Group 3 (diet only): -6.9 kg +/- 1.4<BR/>Group 4 (no treatment): +0.6 kg +/- 0.5<BR/>(3 months)<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus-Vliegen<BR/>1990</P>
</TD>
<TD>
<P>All patients: (mean)<BR/>Week 0: 172 kg<BR/>Week 17: 134.1 kg (-37.9 kg)<BR/>Week 35: 122.2 kg (-11.9 kg)<BR/>
<BR/>Week 0-35: -49.8 kg<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Rigaud<BR/>1994</P>
</TD>
<TD>
<P>Cumulative loss:<BR/>B -8.6 kg<BR/>S -9.1 kg<BR/>
<BR/>1st month: p &lt; 0.001<BR/>2nd,3rd,4th months: p &lt; 0.05<BR/>
<BR/>Balloon:<BR/>Month 1: -5.0 +/- 0.8 kg<BR/>Month 2: -1.5 +/- 1.1 kg<BR/>Month 3: -0.9 +/- 1.1 kg<BR/>Month 4: +0.7 +/- 1.4 kg<BR/>
<BR/>Sham:<BR/>Month 1: -5.1 +/- 1.1 kg<BR/>Month 2: -3.3 +/- 0.7 kg<BR/>Month 3: -1.0 +/- 0.7 kg<BR/>Month 4: -0.3 +/- 0.9 kg<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus-Vliegen<BR/>2005</P>
</TD>
<TD>
<P>Months 0-3:<BR/>Sham -11.2 kg (9.0%)<BR/>Balloon -12.9 kg (10.4%)<BR/>
<BR/>Months 3-6:<BR/>B -8.8 kg (7.9%) (patients who had sham therapy in months 0-3)<BR/>B -3.9 kg (3.5%) (their second balloon treatment period)<BR/>
<BR/>After 6 months:<BR/>The overall weight loss was:<BR/>Sham/balloon -20 kg (16.1%)<BR/>Balloon/balloon -16.7 kg (13.4%)<BR/>(not significant)<BR/>
<BR/>In 33 patients who had completed the study according to protocol, weight loss was:<BR/>-20.5% (-25.6 kg) after 1 year<BR/>-11.4% (-14.6 kg) after 2 years<BR/>55% maintained a weight loss of greater than 10%<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Abbreviations used:<BR/>Sham (S) = sham operation<BR/>Bubble (B) = intragastric balloon</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2008-11-10 10:51:21 +0100" MODIFIED_BY="Gudrun Paletta" NO="5">
<TITLE MODIFIED="2008-11-10 10:45:58 +0100" MODIFIED_BY="Gudrun Paletta">Weight change (body mass index - BMI)</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-10 10:51:21 +0100" MODIFIED_BY="Gudrun Paletta">
<TABLE COLS="2" ROWS="8">
<TR>
<TH>
<P>Publication</P>
</TH>
<TH>
<P>Weight change kg/m2</P>
</TH>
</TR>
<TR>
<TD>
<P>Benjamin<BR/>1988</P>
</TD>
<TD>
<P>First 12 weeks:<BR/>BS = -3.1<BR/>SB = -2.3<BR/>BB = -2.9<BR/>(no statistical significant differences between these groups)<BR/>
<BR/>(BS x SB: p=0.3)<BR/>(BS x BB: p=0.6)<BR/>(SB x BB: p=0.6)<BR/>
<BR/>Last 12 weeks:<BR/>BS = 0.0<BR/>SB = - 0.07<BR/>BB = - 0.4 kg<BR/>(no statistical significant differences between these groups)<BR/>
<BR/>(BS x SB p=0.3)<BR/>(BS x BB p=0.5)<BR/>(SB x BB p=0.6)<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Meshkinpour<BR/>1988</P>
</TD>
<TD>
<P>Sham: - 4.9 %<BR/>Balloon: - 5.3 %<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Hogan<BR/>1989</P>
</TD>
<TD>
<P>Balloon = -3.0<BR/>Sham = -3.5<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus-Vliegen<BR/>1990</P>
</TD>
<TD>
<P>All patients (mean):<BR/>
<BR/>Week 0: 54.6<BR/>Week 17: 42.7 (-11.9)<BR/>Week 35: 38.8 (-3.9)<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Rigaud<BR/>1994</P>
</TD>
<TD>
<P>B: 45.4 +/- 3.3 to 42.2 +/- 3.3<BR/>S: 42.8 +/- 3.3 to 39.5 +/- 2.6<BR/>
<BR/>P&lt;0.05<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Abbreviations used:<BR/>Sham (S) = sham operation<BR/>Bubble (B) = intragastric balloon</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2008-11-10 10:51:32 +0100" MODIFIED_BY="Gudrun Paletta" NO="6">
<TITLE MODIFIED="2008-11-10 10:46:08 +0100" MODIFIED_BY="Gudrun Paletta">Technical failure</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-10 10:51:32 +0100" MODIFIED_BY="Gudrun Paletta">
<TABLE COLS="2" ROWS="8">
<TR>
<TH>
<P>Publication</P>
</TH>
<TH>
<P>Technical failure</P>
</TH>
</TR>
<TR>
<TD>
<P>Lindor<BR/>1987</P>
</TD>
<TD>
<P>8 in 10 balloons were found deflated.<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Benjamin<BR/>1988</P>
</TD>
<TD>
<P>Inability in one case to tolerate crossover endoscopy.</P>
</TD>
</TR>
<TR>
<TD>
<P>Meshkinpour<BR/>1988</P>
</TD>
<TD>
<P>One case passed the bubble.<BR/>Deflated device in once case.<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Hogan<BR/>1989</P>
</TD>
<TD>
<P>Normal balloons or over 70% full: 25<BR/>Half empty balloons: 9<BR/>Completely deflated balloons: 4<BR/>Over 50% deflated balloons: 4<BR/>9 of the 59 patients did not go to 80% of the scheduled meetings<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus-Vliegen<BR/>2005</P>
</TD>
<TD>
<P>Three losses<BR/>Deflated device:<BR/>1.6% (2/128)<BR/>2.3% (3/128)<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Abbreviations used:<BR/>Sham (S) = sham operation<BR/>Bubble (B) = intragastric balloon</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-07" MODIFIED="2008-11-10 10:51:55 +0100" MODIFIED_BY="Gudrun Paletta" NO="7">
<TITLE MODIFIED="2008-11-10 10:46:18 +0100" MODIFIED_BY="Gudrun Paletta">Revision rates</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-10 10:51:55 +0100" MODIFIED_BY="Gudrun Paletta">
<TABLE COLS="2" ROWS="10">
<TR>
<TH>
<P>Publication</P>
</TH>
<TH>
<P>Revision rates</P>
</TH>
</TR>
<TR>
<TD>
<P>Benjamin<BR/>1988</P>
</TD>
<TD>
<P>29 losses (excluded)<BR/>8 lost to follow-up<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Meshkinpour<BR/>1988</P>
</TD>
<TD>
<P>2 losses<BR/>1 passed the bubble<BR/>1 deflated device<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Hogan<BR/>1989</P>
</TD>
<TD>
<P>6 losses<BR/>1 died<BR/>2 moved away<BR/>1 invalid initial weight<BR/>2 realized they were not using the balloon<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Ramhamdany<BR/>1989</P>
</TD>
<TD>
<P>8 losses<BR/>5 put on weight<BR/>2 did not lose weight<BR/>1 did not attend follow up<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Geliebter<BR/>1990</P>
</TD>
<TD>
<P>16 losses<BR/>Group A: 3<BR/>Group B: 3<BR/>Group C: 1<BR/>Group D: 9<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus-Vliegen<BR/>1990</P>
</TD>
<TD>
<P>3 losses<BR/>1 balloon removed after gastric complaints<BR/>1 did not attend the visits to the clinic for legitimate reasons<BR/>1 incooperative behavior at the time of balloon insertion after initially compliant work-up<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus Vliegen<BR/>2005</P>
</TD>
<TD>
<P>10 excluded</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Abbreviations used:<BR/>Sham (S) = sham operation<BR/>Bubble (B) = intragastric balloon</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-08" MODIFIED="2008-11-10 10:52:03 +0100" MODIFIED_BY="Gudrun Paletta" NO="8">
<TITLE MODIFIED="2008-11-10 10:46:32 +0100" MODIFIED_BY="Gudrun Paletta">Major complications</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-10 10:52:03 +0100" MODIFIED_BY="Gudrun Paletta">
<TABLE COLS="2" ROWS="4">
<TR>
<TH>
<P>Publication</P>
</TH>
<TH>
<P>Major complications</P>
</TH>
</TR>
<TR>
<TD>
<P>Lindor<BR/>1987</P>
</TD>
<TD>
<P>Balloon group:<BR/>Migration of a deflated balloon through the intestinal tract in one patient<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Benjamin<BR/>1988</P>
</TD>
<TD>
<P>Small bowel obstruction (2%)<BR/>Mallory-Weiss tears (11%)<BR/>Oesophageal laceration (1%)<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Meshkinpour<BR/>1988</P>
</TD>
<TD>
<P>Migration of deflated balloon through abdominal tract in one case</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-09" MODIFIED="2008-11-10 10:52:10 +0100" MODIFIED_BY="Gudrun Paletta" NO="9">
<TITLE MODIFIED="2008-11-10 10:46:41 +0100" MODIFIED_BY="Gudrun Paletta">Minor complications</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-10 10:52:10 +0100" MODIFIED_BY="Gudrun Paletta">
<TABLE COLS="2" ROWS="12">
<TR>
<TH>
<P>Publication</P>
</TH>
<TH>
<P>Minor complications</P>
</TH>
</TR>
<TR>
<TD>
<P>Lindor<BR/>1987</P>
</TD>
<TD>
<P>Sham group: Gastric erosions associated with the use of aspirin - 2 patients;<BR/>Balloon group: Abdominal pain and withdrawing in 3 days after balloon insertion - 1 patient.<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Benjamin<BR/>1988</P>
</TD>
<TD>
<P># 23 Gastric erosions (26%)<BR/>20 varioliform erosions<BR/>03 hyperplasia of gastric epithelium covered by acute inflammatory infiltrate<BR/># 3 Gastric ulcers + pain (14%)<BR/># 11 requested withdrawal without reason<BR/># 2 became pregnant during study<BR/># 1 Abdominal pain, no ulcera found<BR/># 3 Small bowel obstruction (2%)<BR/># 8 Lost to follow-up<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Meshkinpour<BR/>1988</P>
</TD>
<TD>
<P>Gastric Ulcers - 2 patients<BR/>Abdominal cramps - 17 patients<BR/>Nausea<BR/>Vomiting<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Hogan<BR/>1989</P>
</TD>
<TD>
<P>Dyspepsia<BR/>Gastric antral ulcers: 2 patients<BR/>Erosions in mucosa: 2 patients<BR/>Erosions in gastric-oesophageal junction: 4 patients<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Ramhamdany<BR/>1989</P>
</TD>
<TD>
<P>Abdominal discomfort: 7 balloon + 0 sham<BR/>Abdominal cramps: 8 balloon + 0 sham<BR/>Abdominal fullness: 6 balloon + 0 sham<BR/>Vomiting: 5 balloon + 1 sham<BR/>Nausea: 10 balloon + 4 sham<BR/>Flatulence: 6 balloon + 4 sham<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Geliebter<BR/>1990</P>
</TD>
<TD>
<P>Gastric spasms<BR/>Nausea<BR/>Ulcers<BR/>Superficial erosions<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus-Vliegen<BR/>1990</P>
</TD>
<TD>
<P>Balloon patients:<BR/>Hiccups<BR/>Gastric fullness<BR/>2 patients with ulcers<BR/>After the second period 2 patients had raised erosions in antrum<BR/>1 had reflux oesophagitis<BR/>
<BR/>Footnote added to questionnaires:<BR/>"&#8230;lying on right side relieved the complaints"<BR/>
<BR/>61% were sure not to have the balloon<BR/>
<BR/>Sham-treated patients:<BR/>Nausea<BR/>Heartburn<BR/>Belching<BR/>1 patient with ulcer<BR/>
<BR/>36% were sure that they felt a balloon after the sham operation<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Rigaud<BR/>1994</P>
</TD>
<TD>
<P>Sensation of balloon presence<BR/>Gastric distension<BR/>Hunger sensation<BR/>
<BR/>There was a considerable correlation between the distension and the presence of the sensation of a balloon (r=0.901, p&lt;0.001) and a negative correlation between hunger and the sensation of distension (r=0.8, p&lt;0.0001)<BR/>
<BR/>
<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus-Vliegen<BR/>2005</P>
</TD>
<TD>
<P>Gastric erosions<BR/>Gastric ulcers<BR/>Minor gastric bleeding<BR/>Mallory-Weiss tears<BR/>Oesophageal lacerations<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Abbreviations used:<BR/>Sham (S) = sham operation<BR/>Bubble (B) = intragastric balloon</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-10" MODIFIED="2008-11-10 10:52:19 +0100" MODIFIED_BY="Gudrun Paletta" NO="10">
<TITLE MODIFIED="2008-11-10 10:46:53 +0100" MODIFIED_BY="Gudrun Paletta">Comorbidity</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-10 10:52:19 +0100" MODIFIED_BY="Gudrun Paletta">
<TABLE COLS="2" ROWS="3">
<TR>
<TH>
<P>Publication</P>
</TH>
<TH>
<P>Comorbidity</P>
</TH>
</TR>
<TR>
<TD>
<P>Rigaud<BR/>1994</P>
</TD>
<TD>
<P>Respiratory Insufficiency<BR/>HAS<BR/>DM<BR/>Initially the glycaemic curve suggested hyperglycemia and insulin resistance; it was discrete in the values of glucose after 120 min in the 4th month, when compared to the baseline values (7.3 +- 0.8 mmol/L and 9.7 +- 1.2 mmol/L).<BR/>Initially, the value was lower in the group of balloon treated patients in relation to the control group (60, 90 and 120 min, p&lt;0.05).<BR/>The final value was only significantly different (p&lt;0.05) between the balloon group and the control (8.9 +- 0.78 versus 10.16 +- 0.54) after 60 minutes.<BR/>After 120 minutes there was no return to the initial values in both groups.<BR/>Triglycerides, total cholesterol, HDL and LDL cholesterol did not show changes during the test period.<BR/>
<BR/>
<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Mathus-Vliegen<BR/>2005</P>
</TD>
<TD>
<P>47% of all patients sustained a greater than 10% weight loss, with considerably reduced comorbidity.</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-11" MODIFIED="2008-11-10 10:52:30 +0100" MODIFIED_BY="Gudrun Paletta" NO="11">
<TITLE MODIFIED="2008-11-10 10:47:13 +0100" MODIFIED_BY="Gudrun Paletta">Costs</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-10 10:52:30 +0100" MODIFIED_BY="Gudrun Paletta">
<TABLE COLS="2" ROWS="3">
<TR>
<TH>
<P>Publication</P>
</TH>
<TH>
<P>Costs</P>
</TH>
</TR>
<TR>
<TD>
<P>Lindor<BR/>1987</P>
</TD>
<TD>
<P>The balloon and introduction costs were approximately 313 Euro (400 U.S. $). The endoscopic charges for insertion and removal of each balloon were 940 to 1254 Euro (1200 to 1600 U.S. $). In three months of this study, this translated into an additional 470 Euro (600 U.S. $) for each kilogram of weight lost with the balloon treatment.</P>
</TD>
</TR>
<TR>
<TD>
<P>Hogan<BR/>1989</P>
</TD>
<TD>
<P>The costs were 392 Euro (500 U.S. $) per balloon with accessories plus hospital and physician charges. A recent survey suggested an average cost of up to 3135 Euro (4000 U.S. $) for a four month treatment</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>